Parasetamol

RX_PARASETAMOL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N02BE01 1 out of 7 registries used, show all original rules.	238824
4. Check minimum number of events Min. number of events 3	238824
5. Include endpoints None	238824
6. Filter based on genotype QC (FinnGen only)	230754

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_PARASETAMOL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N02BE01
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Parasetamol based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	230754	143917	86837
Unadjusted period prevalence (%)	46.81	51.05	39.78
Median age at first event (years)	56.87	54.07	61.51

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
54902: Matched controls
278139

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

322.5

5231

14664

C09CA01

ATC

losartan; oral

1.7

322.4

8834

28924

R51

ICD-10 Finland

Headache

2.5

321.8

2539

5299

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

320.5

3869

9743

T82

ICPC

Obesity

3.1

320.5

1689

2809

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

320.3

4046

10369

ZXA10

NOMESCO Finland

Bilateral

1.8

320.3

6804

20758

207

Kela drug reimbursment

Chronic arrhythmias

2.0

320.2

4588

12319

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

320.1

3338

7919

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

318.6

3926

9965

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.4

318.0

2626

5604

R05

ICD-10 Finland

Cough

1.7

316.1

8492

27645

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.0

315.6

1782

3093

L84

ICPC

Back syndrome without radiat pain

2.9

314.9

1821

3207

S80.0

ICD-10 Finland

Contusion of knee

2.2

313.0

3128

7284

K10.3

ICD-10 Finland

Alveolitis of jaws

2.7

312.9

2153

4185

S29

ICPC

Skin symptom/complaint other

1.7

312.8

7504

23688

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

310.9

4745

13021

XKD00

NOMESCO Finland

Uroflowmetry

1.8

310.8

5617

16302

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

310.4

3341

8029

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.7

310.2

2106

4064

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.8

309.7

925

987

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

309.0

2238

4470

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

308.3

2928

6666

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.5

307.7

983

1117

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

5.3

307.7

983

958

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

307.7

18411

68141

D01

ICPC

Abdominal pain/cramps general

2.1

307.7

5462

13843

SPAT1301

SPAT

No procedures

2.0

307.7

14518

41907

R52.9

ICD-10 Finland

Pain, unspecified

2.5

307.7

4097

8679

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.6

307.7

4211

6200

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

307.7

9328

25000

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

307.7

11545

35480

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

307.7

8587

25996

L01

ICPC

Neck symptom/complaint

2.3

307.7

7056

16843

WX290

NOMESCO Finland

Other blockage of nerve

1.8

307.7

24974

89181

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.1

307.7

1304

1640

R05

ICPC

Cough

1.9

307.7

10614

31770

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

307.7

8322

20101

R03BB04

ATC

tiotropium bromide; inhalant

2.2

307.7

3487

8254

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

307.7

17147

55554

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

307.7

15956

49647

SPAT1097

SPAT

Recording of ECG

2.1

307.7

5041

12977

M01AX05

ATC

glucosamine; oral

2.6

307.7

6137

12990

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

307.7

1983

3506

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

23576

82275

R4110

NOMESCO Finland

Physiotherapy

2.0

307.7

11856

34266

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.4

307.7

6881

11311

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

307.7

12235

33230

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

307.7

5968

15838

J45

ICD-10 Finland

Asthma

2.2

307.7

4228

10151

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

307.7

5413

15330

M54.6

ICD-10 Finland

Pain in thoracic spine

2.5

307.7

3145

6547

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

307.7

4673

8960

R4110, ,

SPAT

2.7

307.7

3036

5884

N06AX21

ATC

duloxetine; oral

3.8

307.7

5712

8284

M48.0

ICD-10 Finland

Spinal stenosis

3.9

307.7

4327

6036

A98

ICPC

Health maint/preventive medicine

2.4

307.7

51451

239342

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

307.7

4213

8924

M01AB05

ATC

diclofenac; systemic, rectal

2.2

307.7

33389

115698

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.8

307.7

2475

3409

M04AA01

ATC

allopurinol; systemic

2.1

307.7

4574

11701

Z71.8

ICD-10 Finland

Other specified counselling

1.7

307.7

14340

48814

R74

ICPC

Upper respiratory infection acute

1.7

307.7

16534

56858

M01AH02

ATC

rofecoxib; oral

2.1

307.7

4168

10452

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.5

307.7

11088

25345

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.1

307.7

1691

2156

P20

ICPC

Memory disturbance

2.2

307.7

3672

8949

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

307.7

19069

60962

R06AE07

ATC

cetirizine; oral

1.7

307.7

21375

74570

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

3.7

307.7

1409

1991

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

5.5

307.7

1319

1245

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

11618

29284

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

307.7

4420

8833

L90

ICPC

Osteoarthrosis of knee

4.7

307.7

1934

2132

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

307.7

3347

7864

J01FF01

ATC

clindamycin; systemic

2.0

307.7

12416

35439

B01AB05

ATC

enoxaparin; parenteral

2.8

307.7

14050

30460

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.6

307.7

1574

2278

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

307.7

26668

94656

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

307.7

10010

33618

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

307.7

4692

8313

N06AB06

ATC

sertraline; oral

1.9

307.7

5171

14140

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

307.7

34677

145646

N89

ICPC

Migraine

3.0

307.7

1876

3213

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

307.7

3688

8844

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

307.7

11843

30871

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

307.7

12645

32399

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

307.7

4946

12207

M54.4

ICD-10 Finland

Lumbago with sciatica

3.5

307.7

9017

14768

J01AA02

ATC

doxycycline; systemic

2.0

307.7

38118

147943

C09AA05

ATC

ramipril; oral

1.7

307.7

8569

27792

L13

ICPC

Hip symptom/complaint

2.9

307.7

6816

13069

J02AC01

ATC

fluconazole; systemic

1.5

307.7

16503

60994

SPAT1312

SPAT

General health counselling

1.7

307.7

14903

50779

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

18818

67528

R06AX27

ATC

desloratadine; oral

1.6

307.7

13514

46143

A06AD11

ATC

lactulose; oral

2.3

307.7

5774

13285

R03BA05

ATC

fluticasone; inhalant

1.7

307.7

7789

24313

A02BC02

ATC

pantoprazole; systemic

3.1

307.7

35692

104611

N06AX16

ATC

venlafaxine; oral

2.5

307.7

7098

15323

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.7

307.7

2358

3323

ACC51

NOMESCO Finland

Release of median nerve

3.2

307.7

2832

4694

N02BF02

ATC

pregabalin; oral

5.1

307.7

2612

2704

M17.1

ICD-10 Finland

Other primary gonarthrosis

3.3

307.7

8057

13861

N06AX11

ATC

mirtazapine; oral

2.4

307.7

17018

43996

ZXA05

NOMESCO Finland

Left side

2.0

307.7

9800

27262

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

307.7

8518

22749

N05CF01

ATC

zopiclone; oral

2.1

307.7

14159

40174

G47.3

ICD-10 Finland

Sleep apnoea

2.1

307.7

10015

26980

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

307.7

7218

16207

N05AH04

ATC

quetiapine; oral

2.5

307.7

9656

21492

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.3

307.7

3101

6942

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

307.7

4204

10298

SFA10

NOMESCO Finland

One-surface restoration

1.7

307.7

27538

104357

M54.3

ICD-10 Finland

Sciatica

3.0

307.7

2240

3827

N05BA01

ATC

diazepam; systemic, rectal

2.1

307.7

5282

13192

ZXD05

NOMESCO Finland

Urgent procedure

2.0

307.7

14708

43902

WZC30

NOMESCO Finland

Teaching

2.1

307.7

6153

15862

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.6

307.7

2452

4994

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

307.7

16072

56274

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.5

307.7

5262

11481

SPAT1325

SPAT

Vaccination

1.5

307.7

13176

47449

S97

ICPC

Chronic ulcer skin

3.5

307.7

2058

3078

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

307.7

8186

24780

J01MA14

ATC

moxifloxacin; systemic

2.2

307.7

3378

8009

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

307.7

9229

25074

H02AB06

ATC

prednisolone; systemic

2.3

307.7

23400

69007

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

307.7

4736

11378

R50.9

ICD-10 Finland

Fever, unspecified

2.0

307.7

6759

18117

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

307.7

21249

65940

N02AX02

ATC

tramadol; systemic, rectal

3.6

307.7

23366

47654

L12

ICPC

Hand/finger symptom/complaint

2.0

307.7

7182

19411

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

307.7

5048

12051

S06.0

ICD-10 Finland

Concussion

2.3

307.7

4951

11671

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

307.7

12178

31111

N04BC05

ATC

pramipexole; oral

2.7

307.7

2535

4964

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.1

307.7

5673

4430

R51.80

ICD-10 Finland

Headache

2.9

307.7

8410

16502

D11

ICPC

Diarrhoea

2.0

307.7

5613

14684

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

307.7

5932

13907

R5110, ,

SPAT

3.1

307.7

1999

3346

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

307.7

4168

10250

B01AF01

ATC

rivaroxaban; oral

2.9

307.7

4204

7649

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

307.7

8665

23936

C10AA01

ATC

simvastatin; oral

1.6

307.7

14478

49762

N02BF01

ATC

gabapentin; oral

5.4

307.7

3720

3671

P01AB01

ATC

metronidazole; oral, rectal

1.9

307.7

18437

59051

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

307.7

3997

7826

WZA00

NOMESCO Finland

Concise certificate

2.6

307.7

2789

5696

X58

ICD-10 Finland

Exposure to other specified factors

2.1

307.7

6857

17433

N06AA09

ATC

amitriptyline; systemic

2.9

307.7

3347

6151

N02AJ06

ATC

codeine and paracetamol; systemic

3.4

307.7

23859

51545

M54

ICD-10 Finland

Dorsalgia

2.5

307.7

6034

13298

A46

ICD-10 Finland

Erysipelas

2.2

307.7

5565

13706

N02BE01

ATC

paracetamol; systemic, rectal

+∞

307.7

54902

158721

C03CA01

ATC

furosemide; systemic

2.2

307.7

11391

29012

M79.7

ICD-10 Finland

Fibromyalgia

4.9

307.7

1317

1387

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

307.7

8000

18847

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

307.7

7730

20743

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

307.7

9362

27191

M79.6

ICD-10 Finland

Pain in limb

2.7

307.7

21459

53378

A02BC01

ATC

omeprazole; systemic

2.1

307.7

12059

33393

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

307.7

12647

33975

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

307.7

5044

12645

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.9

307.7

3062

5609

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

307.7

4937

12619

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.9

307.7

13191

27041

B01AF02

ATC

apixaban; oral

2.2

307.7

3711

8719

UJF32

NOMESCO Finland

Coloscopy

2.1

307.7

10551

28521

M02AA10

ATC

ketoprofen; topical

2.1

307.7

6010

15492

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.2

307.7

3946

4999

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

307.7

3612

8012

SPAT1240

SPAT

Therapeutic discussion

2.0

307.7

5330

14238

L11

ICPC

Wrist symptom/complaint

2.1

307.7

3802

9358

C09CA06

ATC

candesartan; oral

1.7

307.7

9318

29540

J01DB01

ATC

cefalexin; oral

2.8

307.7

45017

171792

A02BA02

ATC

ranitidine; systemic

1.8

307.7

6939

20367

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

307.7

7480

23384

T90

ICPC

Diabetes non-insulin dependent

2.0

307.7

8683

24169

SPAT1263

SPAT

Sampling

2.1

307.7

21066

64508

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

5.7

307.7

2256

2069

C08CA01

ATC

amlodipine; oral

1.8

307.7

14306

44646

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

307.7

9561

25380

N01

ICPC

Headache

2.2

307.7

6019

15030

A04

ICPC

Weakness/tiredness general

1.9

307.7

6310

17617

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

4.2

307.7

5075

6584

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

307.7

7568

21904

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.1

307.7

2538

4341

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

18852

54404

A28

ICPC

Limited function/disability NOS

2.9

307.7

5940

11227

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

307.7

10604

27943

L28

ICPC

Limited function/disability (L)

3.3

307.7

7039

11961

J01MA12

ATC

levofloxacin; systemic

2.1

307.7

7430

19640

N03AX09

ATC

lamotrigine; oral

2.7

307.7

2287

4458

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.0

307.7

6688

12361

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

307.7

26680

96314

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.2

307.7

3938

9235

N30.0

ICD-10 Finland

Acute cystitis

1.8

307.7

6214

18212

M70.6

ICD-10 Finland

Trochanteric bursitis

3.4

307.7

4591

7177

E66.01

ICD-10 Finland

Obesity due to excess calories

3.2

307.7

4366

7402

A01

ICPC

Pain general/multiple sites

3.5

307.7

3875

5921

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

307.7

2535

5069

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.8

307.7

4852

6958

M01AE01

ATC

ibuprofen; systemic, rectal

2.7

307.7

48591

205627

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

307.7

7185

21203

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

307.7

5333

12610

R96

ICPC

Asthma

2.4

307.7

3629

8123

N06AB04

ATC

citalopram; systemic

1.9

307.7

8818

25723

SPAT1254

SPAT

Administration of medicine

2.5

307.7

7008

15162

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

29115

113078

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

307.7

2641

5388

J01FA06

ATC

roxithromycin; oral

1.6

307.7

17310

60769

OAB93, ,

SPAT

2.4

307.7

2808

6051

J01FA10

ATC

azithromycin; systemic

1.5

307.7

28385

114687

L15

ICPC

Knee symptom/complaint

2.5

307.7

10556

24478

A02BC03

ATC

lansoprazole; oral

2.1

307.7

11896

33030

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

307.7

14892

44649

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.9

307.7

27855

99045

SPAT1255

SPAT

Intravenous administration of medicine

3.0

307.7

2641

4565

K02.1

ICD-10 Finland

Caries of dentine

1.7

307.7

30643

117161

L16

ICPC

Ankle symptom/complaint

2.2

307.7

5017

12218

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

307.7

5598

15406

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

307.7

3595

7891

R01AD58

ATC

fluticasone, combinations; nasal

1.8

307.7

11983

36987

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

307.7

12617

33448

OAA65, ,

SPAT

1.7

307.7

8179

26204

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

307.7

3416

7449

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

307.7

2005

3634

M01AC06

ATC

meloxicam; systemic, rectal

2.2

307.7

15907

42798

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

307.7

3424

6941

C07AB07

ATC

bisoprolol; oral

2.0

307.7

20185

62668

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.1

307.7

5315

9298

M01AE02

ATC

naproxen; oral, rectal

2.1

307.7

29599

100334

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

4.4

307.7

1666

1962

L29

ICPC

Musculoskeletal sympt/complt other

2.3

307.7

3199

7354

S18

ICPC

Laceration/cut

2.3

307.7

21687

61025

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.6

307.7

2220

3198

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

307.7

9381

31040

NF1AA

NOMESCO Finland

Hip X-ray examination

4.3

307.7

3092

3775

SPAT1211

SPAT

Application of soft bandage

2.4

307.7

3631

8058

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

307.7

34213

139598

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

10683

30585

J20

ICD-10 Finland

Acute bronchitis

2.2

307.7

4103

10052

WX402

NOMESCO Finland

General anaesthesia

2.1

307.7

9616

25661

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

28136

93539

WX320

NOMESCO Finland

Spinalanesthesy

2.6

307.7

10372

23229

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

307.7

2808

5614

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.6

307.7

5832

12273

L17

ICPC

Foot/toe symptom/complaint

2.2

307.7

12977

34836

N05BA04

ATC

oxazepam; oral

2.2

307.7

12286

32394

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

307.7

21305

56953

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

19216

53271

WX002

NOMESCO Finland

Sedation and analgesia

2.2

307.7

7741

19118

J01CA04

ATC

amoxicillin; systemic

1.9

307.7

42966

182535

J01DA01

ATC

[U] cefalexin

1.6

307.7

29484

118455

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.4

307.7

2668

4151

L89

ICPC

Osteoarthrosis of hip

4.9

307.7

944

983

M03BC01

ATC

orphenadrine (citrate); systemic

2.7

307.7

11621

24975

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

307.7

9988

27924

G04BD12

ATC

mirabegron; oral

2.3

307.7

3535

8116

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

307.7

9164

27490

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

307.7

16110

46753

N05CF02

ATC

zolpidem; oral

2.0

307.7

7292

19981

N03AX16

ATC

[U] pregabalin

4.2

307.7

11805

17066

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.4

307.7

3410

5335

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

307.7

10940

33158

N03AX12

ATC

[U] gabapentin; oral

4.9

307.7

8197

9709

J01MA02

ATC

ciprofloxacin; systemic

1.8

307.7

17318

55810

L08

ICPC

Shoulder symptom/complaint

2.4

307.7

9393

22424

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.8

307.7

2442

3378

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

307.7

8604

20949

B01AB10

ATC

tinzaparin; parenteral

2.8

307.7

3820

7337

R07.3

ICD-10 Finland

Other chest pain

2.2

307.7

3927

9432

A10BA02

ATC

metformin; oral

1.7

307.7

10727

34053

M54.5

ICD-10 Finland

Low back pain

3.1

307.7

19842

43036

ZXE00

NOMESCO Finland

One hour or less

1.7

307.7

17603

60830

W19

ICD-10 Finland

Unspecified fall

2.1

307.7

3925

9853

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

307.7

3137

7176

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

307.7

9709

29099

C10AA05

ATC

atorvastatin; oral

1.6

307.7

15099

52150

R21

ICPC

Throat symptom/complaint

1.6

307.7

10848

36760

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

5.9

307.7

3634

3314

R60.0

ICD-10 Finland

Localized oedema

2.5

307.7

4432

9497

G44.2

ICD-10 Finland

Tension-type headache

2.8

307.7

6639

13222

M79.1

ICD-10 Finland

Myalgia

2.4

307.7

6750

15300

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.0

307.7

23796

56683

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

11361

31304

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.7

307.7

3509

6927

N06AB10

ATC

escitalopram; oral

1.9

307.7

10322

30292

L03

ICPC

Low back symptom/complaint

2.7

307.7

14006

31497

AA1AD

NOMESCO Finland

CT of head and brain

2.4

307.7

11374

27350

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.5

307.7

3982

8474

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

307.7

4196

10757

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

307.7

6778

17026

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.2

307.7

4073

9926

R01AD09

ATC

mometasone; nasal

1.7

307.7

22042

77508

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

11937

38348

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

307.7

17719

61474

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.2

307.7

3735

9030

E66.8

ICD-10 Finland

Other obesity

3.5

307.7

2512

3716

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

307.7

16436

58342

L86

ICPC

Back syndrome with radiating pain

4.1

307.7

2448

3157

C07AA05

ATC

propranolol; systemic

1.8

307.7

9196

28134

SPAT1153

SPAT

Removal of sutures

2.3

307.7

13604

35436

R11

ICD-10 Finland

Nausea and vomiting

2.3

307.7

3691

8458

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.2

307.7

4613

5893

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

307.7

6672

16402

B01AA03

ATC

warfarin; systemic

1.9

307.7

6643

18673

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.7

307.7

2458

4829

G04CA02

ATC

tamsulosin; oral

1.8

307.7

9143

28233

SPAT1262

SPAT

Handing over of treatment supplies

2.1

307.7

6860

17505

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

307.7

37826

141328

M01AH05

ATC

etoricoxib; oral

2.6

307.7

32117

97522

M03BX02

ATC

tizanidine; oral

2.5

307.7

32832

103623

B01AC04

ATC

clopidogrel; oral

2.0

307.7

5245

14234

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

307.7

11969

32002

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

307.7

4563

11380

SPAT1216

SPAT

Assessment of functional ability

2.7

307.7

5733

11484

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

307.7

18802

71058

D07AC01

ATC

betamethasone; topical

1.6

307.7

15521

55446

G43

ICD-10 Finland

Migraine

2.5

307.7

2635

5478

R01AD12

ATC

fluticasone furoate; nasal

1.8

307.7

15487

50772

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

307.7

3631

8668

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

307.7

9217

23173

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

307.7

37680

148209

M16.1

ICD-10 Finland

Other primary coxarthrosis

3.6

307.7

3901

5808

SGA01

NOMESCO Finland

Emergency treatment

1.8

307.7

7876

23408

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

307.7

14486

44480

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

307.7

14043

37362

S22.3

ICD-10 Finland

Fracture of rib

2.6

307.7

2787

5544

SPAT1260

SPAT

Consultation of another employee

2.1

307.7

7504

19739

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.4

307.7

1778

2711

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

307.7

6511

15391

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.8

307.7

5764

11038

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.8

307.7

12046

38208

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.1

307.7

3657

6253

KMAK, ,

NOMESCO Finland

1.5

307.7

24480

97080

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.0

307.7

2255

2937

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

5.1

307.7

1007

1009

Z3226

NOMESCO Finland

Physiotherapist

2.0

307.7

7441

20473

SPAT1104

SPAT

Monitoring of emergency patient

2.7

307.7

2448

4755

P06

ICPC

Sleep disturbance

2.0

307.7

5284

14120

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

307.7

6003

15975

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.9

307.7

3551

6577

D06

ICPC

Abdominal pain localized other

2.2

307.7

3592

8740

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.8

307.7

1721

2371

R52.2

ICD-10 Finland

Other chronic pain

4.2

307.7

1432

1749

R03DC03

ATC

montelukast; oral

2.0

307.7

7165

19070

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

307.7

6425

12808

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.9

307.7

1501

1601

EBA00

NOMESCO Finland

Extraction of tooth

1.7

307.7

17562

60083

L02

ICPC

Back symptom/complaint

2.4

307.7

4592

10339

M25.5

ICD-10 Finland

Pain in joint

2.5

307.7

15940

39629

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

307.7

5392

14042

R02

ICPC

Shortness of breath/dyspnoea

2.4

307.7

5251

11788

E0000UV, ,

ATC

1.7

307.7

19506

69017

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

307.7

4853

11176

SPAT1310

SPAT

Counselling related to known health issue

1.8

307.7

14635

46298

J01FA09

ATC

clarithromycin; systemic

1.6

307.7

13743

47884

R01AD08

ATC

fluticasone; nasal

1.6

307.7

12720

43536

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

9234

25367

G43.9

ICD-10 Finland

Migraine, unspecified

3.2

307.7

3160

5285

M01AH01

ATC

celecoxib; oral

2.5

307.7

7033

15388

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

3.8

307.7

2101

2897

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

307.7

8429

23611

M54.2

ICD-10 Finland

Cervicalgia

2.7

307.7

3324

6407

A03

ICPC

Fever

1.8

307.7

8610

25628

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

307.7

10269

33230

WX111

NOMESCO Finland

Local infiltration anesthesia

5.4

307.7

923

884

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.9

307.7

5812

10884

M02AA07

ATC

piroxicam; topical

1.9

307.7

14575

44749

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

307.7

24124

83375

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

307.7

3916

9169

ZXA00

NOMESCO Finland

Right side

2.1

307.7

10651

29181

N02AA05

ATC

oxycodone; systemic

3.7

307.7

7293

10931

SPAT1283

SPAT

Restricted health certificate

1.8

307.7

9826

29363

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

307.7

3597

8670

UKC02

NOMESCO Finland

Cystoscopy

2.0

307.7

5917

15826

M01AX17

ATC

nimesulide; oral

1.9

307.7

8734

24714

SPAT1229

SPAT

Assessment of need for aid

3.8

307.7

2665

3681

M15

ICD-10 Finland

Polyarthrosis

3.6

307.7

1362

1928

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

21689

82980

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

307.7

9663

26632

N02AJ13

ATC

tramadol and paracetamol; systemic

5.7

307.5

779

701

H02AB04

ATC

methylprednisolone; systemic

1.8

306.8

5436

15673

J01EA01

ATC

trimethoprim; systemic

1.6

306.1

9999

34159

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

306.1

3056

7112

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

305.7

5203

14806

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.7

305.3

2038

3896

N06AX12

ATC

bupropion; oral

2.1

301.6

3468

8559

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.3

300.6

2916

6700

M54.1

ICD-10 Finland

Radiculopathy

3.3

300.6

1447

2267

K30

ICD-10 Finland

Functional dyspepsia

2.0

300.6

4348

11703

H01

ICPC

Ear pain/earache

1.8

299.0

5196

14880

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

298.9

14348

53345

A29

ICPC

General symptom/complaint other

1.9

298.0

4619

12733

M10.9

ICD-10 Finland

Gout, unspecified

2.5

297.6

2264

4636

K04.0

ICD-10 Finland

Pulpitis

1.9

297.2

4413

11985

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

297.0

3652

9253

SPAT1053

SPAT

Memory test

2.0

297.0

3802

9783

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

295.2

12401

44809

R03BA02

ATC

budesonide; inhalant

1.7

294.0

7357

23459

L04AX03

ATC

methotrexate; systemic

2.1

293.7

3635

9232

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

293.1

3252

7908

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

292.7

1728

3079

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.6

292.7

2095

4157

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

292.6

3552

8953

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

292.3

2773

6307

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

5.1

291.0

822

830

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

4.5

290.7

930

1058

A99

ICPC

Disease/condition unspecnature/site

2.1

290.5

3486

8747

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

289.4

7389

23679

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.6

288.4

8342

27611

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

285.9

4341

11874

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.1

285.6

3350

8328

L14

ICPC

Leg/thigh symptom/complaint

2.2

285.4

2848

6621

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.1

285.3

1489

2459

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

284.8

16411

63136

E66

ICD-10 Finland

Obesity

2.5

283.0

2151

4401

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

283.0

1515

2543

JN4AD

NOMESCO Finland

Body CT examination

2.1

282.1

3262

8062

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

282.0

5277

15455

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.5

281.8

1218

1769

N03AE01

ATC

clonazepam; systemic

2.6

281.4

2088

4220

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.5

281.3

1239

1824

M43.1

ICD-10 Finland

Spondylolisthesis

3.4

280.8

1270

1905

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.5

279.6

2251

4739

N06AX26

ATC

vortioxetine; oral

2.1

279.6

3362

8438

-1, ,

NOMESCO Finland

1.5

279.6

15743

60251

NG2AA

NOMESCO Finland

Patella X-ray examination

4.6

278.0

863

955

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

277.8

8371

27963

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

276.6

2945

7036

SPAT1058

SPAT

PEF monitoring instruction

2.2

276.5

2893

6861

M13.9

ICD-10 Finland

Arthritis, unspecified

2.2

276.2

2803

6562

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

274.1

3998

10778

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

273.7

3598

9340

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

273.5

6273

19496

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

272.8

5613

16907

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

272.7

1412

2320

R09

ICPC

Sinus symptom/complaint

2.0

272.2

3461

8873

C08CA13

ATC

lercanidipine; oral

1.9

271.5

4410

12333

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

270.8

2215

4698

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

270.6

5366

15984

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

270.4

11283

40587

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

269.6

2532

5728

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.2

269.4

2973

7207

D82

ICPC

Teeth/gum disease

1.4

269.4

17237

67460

C01DA14

ATC

isosorbide mononitrate; oral

1.8

269.2

4894

14192

Z00.0

ICD-10 Finland

General medical examination

1.6

269.2

8073

26916

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

6.2

268.7

632

522

ZX120

NOMESCO Finland

Intravenous

2.0

268.7

3480

8982

C10AA07

ATC

rosuvastatin; oral

1.5

267.2

11108

39910

SPAT1234

SPAT

Support of social functional capacity

2.8

267.1

1651

3020

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

5.4

266.8

711

676

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

265.2

3817

10237

N17

ICPC

Vertigo/dizziness

1.9

264.7

4236

11783

A11

ICPC

Chest pain NOS

2.2

264.6

2773

6578

R52.0

ICD-10 Finland

Acute pain

3.1

264.4

1374

2262

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.0

264.1

983

1273

M54.8

ICD-10 Finland

Other dorsalgia

2.7

262.6

1712

3227

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.8

262.0

5276

15780

N03AG01

ATC

valproic acid; systemic, rectal

2.3

262.0

2451

5534

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.0

261.8

633

540

N05AX08

ATC

risperidone; systemic

2.1

261.4

3265

8309

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

261.4

2425

5454

N06AB03

ATC

fluoxetine; oral

1.8

261.3

4798

13951

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

260.9

4823

14053

L05

ICPC

Flank/axilla symptom/complaint

2.4

260.8

2230

4830

K08.3

ICD-10 Finland

Retained dental root

2.2

260.3

2775

6629

EB1VA, ,

NOMESCO Finland

1.8

259.8

5103

15146

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

259.8

3695

9865

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

258.6

3518

9242

A10BJ06

ATC

semaglutide; parenteral

2.7

258.0

1704

3235

P03

ICPC

Feeling depressed

1.8

257.9

4841

14170

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

257.4

7696

25612

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.6

257.0

1849

3675

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.6

256.8

1902

3838

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

256.1

1975

4068

SPAT1252

SPAT

Overall medication plan or its review

2.4

256.0

2120

4522

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

255.9

2344

5241

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.1

255.2

915

1149

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

3.0

254.2

1416

2435

C10AX09

ATC

ezetimibe; oral

1.8

253.9

5010

14885

R03BA01

ATC

beclometasone; inhalant

1.8

253.6

5251

15826

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

252.4

2529

5883

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

252.4

1545

2810

A04AA01

ATC

ondansetron; systemic, rectal

2.2

252.3

2742

6601

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

252.1

10450

37457

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

251.5

1423

2470

K04.08

ICD-10 Finland

Other specified pulpit

2.0

251.2

3519

9340

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.9

250.0

3881

10677

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

249.8

3323

8655

JN4BD

NOMESCO Finland

Extensive body CT

2.0

249.7

3439

9072

J01CA08

ATC

pivmecillinam; oral

1.4

248.2

15666

60942

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

246.1

2994

7538

M01AB08

ATC

etodolac; oral

2.3

246.1

2357

5375

WX212

NOMESCO Finland

Femoral plexus blockade

5.2

245.1

671

656

A10BK03

ATC

empagliflozin; oral

2.0

245.0

3065

7799

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

244.8

12483

46629

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

243.3

2287

5171

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

243.0

15212

59036

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

242.5

1488

2709

R03AC03

ATC

terbutaline; inhalant

1.7

242.1

5468

16882

D10

ICPC

Vomiting

2.1

242.0

2959

7463

AN1

Coronary angiography

2.0

241.8

3320

8744

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

241.4

9530

33761

J01CF05

ATC

flucloxacillin; systemic

2.2

241.3

2432

5669

J05AB01

ATC

aciclovir; systemic

1.6

241.0

8531

29499

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

240.9

1157

1808

WX704

NOMESCO Finland

Intubation

2.0

240.1

3074

7889

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

5.9

239.9

586

506

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.8

239.3

4639

13696

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.8

239.0

4731

14056

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.6

237.8

1664

3258

A10BH01

ATC

sitagliptin; oral

2.1

237.5

2932

7421

U02

ICPC

Urinary frequency/urgency

1.7

236.5

4954

14964

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

236.0

2730

6736

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

235.5

2281

5225

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

235.5

1960

4188

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

234.7

2019

4382

R33

ICD-10 Finland

Retention of urine

2.1

234.4

2719

6716

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

233.9

6697

22003

R06AX22

ATC

ebastine; oral

1.6

233.9

6886

22781

E000001, ,

ATC

1.5

233.1

8522

29659

A08

ICPC

Swelling

2.8

232.3

1494

2793

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

231.5

4027

11490

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.0

230.5

1259

2138

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

230.2

2388

5633

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

230.1

4011

11452

C07AB02

ATC

metoprolol; systemic

1.6

229.7

6743

22283

U04

ICPC

Incontinence urine

2.8

229.7

1469

2738

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

229.6

9374

33404

S10

ICPC

Boil/carbuncle

2.3

229.6

2237

5137

P76

ICPC

Depressive disorder

2.0

228.5

2939

7552

A02BC04

ATC

rabeprazole; oral

2.0

228.4

3127

8222

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

224.9

4546

13579

P29

ICPC

Psychological sympt/compl other

1.9

224.5

3393

9237

K78

ICPC

Atrial fibrillation/flutter

2.3

224.4

2109

4766

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

224.3

1858

3960

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

224.2

2189

5030

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.2

224.1

1131

1826

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

223.2

1626

3250

H02AB07

ATC

prednisone; oral

1.7

223.2

4892

14956

P01BA02

ATC

hydroxychloroquine; oral

2.1

222.9

2714

6828

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

222.3

1797

3785

S70.0

ICD-10 Finland

Contusion of hip

2.9

221.1

1300

2308

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

220.7

879

1200

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

220.0

2057

4637

N07BB01

ATC

disulfiram; oral

2.4

219.5

1796

3805

Z2446

NOMESCO Finland

Social worker

2.1

219.1

2672

6726

R4120

NOMESCO Finland

Occupational therapy

2.2

219.0

2365

5671

SDA03

NOMESCO Finland

Periodontal treatment

1.4

218.4

17645

71235

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

218.3

4489

13470

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

217.7

2760

7051

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

217.5

4453

13345

D07AC13

ATC

mometasone; topical

1.4

217.4

11760

44258

G54.0

ICD-10 Finland

Brachial plexus disorders

3.3

217.2

1033

1603

SFA00

NOMESCO Finland

Small restoration

1.7

216.8

5472

17382

H03AA01

ATC

levothyroxine sodium; systemic

1.5

216.6

8357

29379

R03BA08

ATC

ciclesonide; inhalant

1.9

216.6

3149

8455

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.4

215.8

976

1463

P01

ICPC

Feeling anxious/nervous/tense

1.6

215.5

6162

20206

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

215.5

2995

7914

N07BA03

ATC

varenicline; oral

2.3

215.4

1930

4267

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

215.1

2244

5304

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

214.0

1888

4144

K08.80

ICD-10 Finland

Toothache NOS

1.8

214.0

3631

10268

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

213.9

5649

18153

SPAT1101

SPAT

Orthostatic test

3.0

213.4

1174

2002

SPAT1210

SPAT

Application of cast or individual aid

2.7

213.3

1466

2841

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.9

213.1

806

1057

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

212.8

6555

21885

A10AE04

ATC

insulin glargine; parenteral

1.9

212.7

3461

9654

N03AX11

ATC

topiramate; oral

3.3

212.5

999

1538

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

212.5

1241

2194

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.4

212.0

701

821

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.3

211.8

991

1521

OAB91, ,

SPAT

2.0

211.1

2886

7579

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

210.4

2330

5644

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

209.6

2665

6813

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

208.9

7412

25559

SPAT1202

SPAT

Intra-articular injection

3.9

208.6

801

1063

L60.0

ICD-10 Finland

Ingrowing nail

2.4

208.5

1805

3927

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

208.2

1486

2938

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

208.2

12146

46290

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

207.5

7572

26273

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

207.0

2466

6148

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.0

206.5

1156

1992

M01AB55

ATC

diclofenac, combinations; oral

2.3

206.2

1916

4305

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

206.2

1779

3864

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

206.1

11431

43152

N02CC07

ATC

frovatriptan; oral

2.5

205.9

1644

3440

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.5

205.8

1595

3289

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

205.4

1829

4031

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

205.4

10410

38634

D02

ICPC

Abdominal pain epigastric

2.2

204.2

2225

5353

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

203.5

2464

6182

R31

ICD-10 Finland

Unspecified haematuria

1.8

203.4

3528

10042

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

202.8

3614

10374

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

201.3

2691

7007

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

201.2

1913

4342

J01

ICD-10 Finland

Acute sinusitis

2.1

200.9

2206

5323

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

200.1

4493

13809

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.3

199.7

1853

4160

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.3

199.3

1901

4321

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

199.2

2561

6572

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

199.0

2278

5589

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

4.4

198.9

658

771

SPAT1360

SPAT

Extensive global examination

2.1

198.7

2421

6087

G43.3

ICD-10 Finland

Complicated migraine

4.0

198.5

731

938

205

Kela drug reimbursment

Chronic hypertension

1.5

198.5

8605

30938

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

198.3

2072

4898

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

197.9

2199

5331

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

196.7

3047

8353

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

196.3

962

1523

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

196.0

1678

3630

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

196.0

1015

1666

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

195.7

3321

9383

D07AA02

ATC

hydrocortisone; topical

1.6

195.6

5976

19882

J46

ICD-10 Finland

Status asthmaticus

3.3

195.4

942

1475

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

194.5

2257

5567

R12

ICD-10 Finland

Heartburn

1.9

194.3

2981

8145

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

194.3

3592

10425

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

193.9

6233

20983

M01AE52

ATC

naproxen and esomeprazole; oral

3.1

193.6

998

1633

N05BA12

ATC

alprazolam; oral

1.8

192.9

3554

10302

C05AA08

ATC

fluocortolone; rectal, topical

1.7

192.6

4793

15139

R55

ICD-10 Finland

Syncope and collapse

1.8

192.4

3867

11508

L09

ICPC

Arm symptom/complaint

2.3

192.3

1777

3981

JAH01

NOMESCO Finland

Laparoscopy

2.4

191.7

1580

3357

R75

ICPC

Sinusitis acute/chronic

2.3

191.5

1799

4060

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

191.3

1968

4620

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

191.0

801

1137

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

190.6

2044

4883

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.1

190.5

2242

5560

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

190.0

3915

11733

R10.0

ICD-10 Finland

Acute abdomen

2.7

189.8

1253

2375

R01AD01

ATC

beclometasone; nasal

1.6

189.3

5771

19179

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.4

189.2

1616

3492

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

189.1

1461

3007

WX892

NOMESCO Finland

Monitored bed care

2.0

189.0

2571

6733

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

188.7

1883

4363

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.4

188.2

610

702

A10BJ02

ATC

liraglutide; parenteral

3.2

187.4

920

1458

R35

ICD-10 Finland

Polyuria

2.1

186.5

2205

5477

K07

ICPC

Swollen ankles/oedema

2.7

186.4

1204

2255

N02CC03

ATC

zolmitriptan; nasal, oral

2.1

186.1

2061

4988

A05

ICPC

Feeling ill

1.9

185.7

2994

8314

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.6

185.4

1306

2563

G04CA01

ATC

alfuzosin; oral

1.7

185.4

4354

13535

S21

ICPC

Skin texture symptom/complaint

1.6

185.1

5172

16820

M77.4

ICD-10 Finland

Metatarsalgia

2.1

184.8

2126

5224

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.3

184.5

1680

3738

K85

ICPC

Elevated blood pressure

1.6

184.2

4798

15327

EBA30

NOMESCO Finland

Extraction of root of tooth

2.2

183.8

1971

4707

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

183.8

1951

4640

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.0

183.8

1005

1707

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.1

183.3

652

813

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

183.2

4119

12650

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.3

182.6

859

1323

S20.2

ICD-10 Finland

Contusion of thorax

2.2

182.5

1953

4660

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.4

181.9

1535

3297

H13

ICPC

Plugged feeling ear

1.5

181.9

6625

22918

N06DX01

ATC

memantine; oral

2.2

181.8

1857

4345

R29

ICPC

Respiratory symptom/complaint other

2.0

181.5

2507

6600

M75.8

ICD-10 Finland

Other shoulder lesions

2.5

181.3

1365

2773

N02CC04

ATC

rizatriptan; oral

2.1

180.9

2178

5447

M09AX01

ATC

hyaluronic acid; parenteral

2.7

180.6

1235

2386

ZXD20

NOMESCO Finland

Day surgery

1.6

180.4

4778

15324

SPAT1167

SPAT

Insertion of urinary catheter

3.3

180.1

862

1343

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.4

179.0

822

1245

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.6

178.4

1299

2594

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.7

178.1

710

970

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.8

178.1

1111

2040

Z2221

NOMESCO Finland

Medical doctor

1.4

178.1

11125

42723

R06AE09

ATC

levocetirizine; oral

1.6

177.8

5861

19817

M01AC01

ATC

piroxicam; systemic, rectal

1.7

177.2

4187

13029

L04

ICPC

Chest symptom/complaint

2.0

176.6

2239

5710

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

176.4

4128

12812

SPAT1281

SPAT

Other administrative function

1.9

175.9

2914

8160

C03DA01

ATC

spironolactone; oral

1.7

175.3

3739

11307

S76

ICPC

Skin infection other

2.2

175.3

1803

4231

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

174.9

3020

8571

M01AH03

ATC

valdecoxib; oral

2.1

174.5

1941

4704

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.2

173.2

1700

3910

N05CD07

ATC

temazepam; oral

1.7

172.8

3727

11306

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

172.7

786

1183

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.6

172.7

1240

2458

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

171.6

5872

20012

C09AA02

ATC

enalapril; systemic

1.5

171.4

6310

21856

G04BD08

ATC

solifenacin; oral

2.2

171.2

1788

4222

NF1DA

NOMESCO Finland

X-ray of hips

4.4

171.2

561

652

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

171.0

5318

17730

N05AH03

ATC

olanzapine; systemic

1.9

170.8

2611

7117

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

6.9

170.7

367

271

Z51.5

ICD-10 Finland

Palliative care

2.0

169.8

2182

5592

U07

ICPC

Urine symptom/complaint other

2.0

169.1

2311

6058

TQW40, ,

SPAT

1.9

168.9

2493

6715

D07AD01

ATC

clobetasol; topical

1.5

168.8

5966

20475

NF3AA

NOMESCO Finland

Femur X-ray examination

4.0

168.8

620

794

S01

ICPC

Pain/tenderness of skin

2.3

168.7

1572

3533

B01AX06

ATC

[U] rivaroxaban

4.6

168.5

526

585

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

168.3

1225

2445

N02CC05

ATC

almotriptan; oral

2.3

168.0

1523

3381

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.9

167.6

2628

7224

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.0

167.6

901

1514

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.4

167.3

775

1181

D19

ICPC

Teeth/gum symptom/complaint

1.4

167.2

12174

47879

J01FA15

ATC

telithromycin; oral

1.7

167.1

3505

10545

J01DA09

ATC

[U] cefadroxil

1.4

167.0

10937

42268

P15

ICPC

Chronic alcohol abuse

2.6

166.9

1196

2368

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

166.6

1150

2232

SPAT1304

SPAT

Counselling and guidance related to ageing

2.2

166.4

1694

3957

L18

ICPC

Muscle pain

2.3

166.3

1489

3287

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

166.2

1936

4778

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

165.7

2930

8374

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

165.2

2651

7343

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.9

165.0

2630

7268

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.5

164.9

1233

2495

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

164.9

1105

2111

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

164.6

977

1743

ZY010

NOMESCO Finland

Hospital outpatient

2.0

164.4

2216

5778

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

164.3

5027

16685

A10BH05

ATC

linagliptin; oral

2.4

163.7

1350

2867

M23.8

ICD-10 Finland

Other internal derangements of knee

2.4

163.7

1411

3060

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

163.6

2243

5885

M05BX04

ATC

denosumab; parenteral

2.4

163.4

1372

2939

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

163.3

1668

3901

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

163.3

1871

4587

A10AB05

ATC

insulin aspart; parenteral

1.8

163.2

2790

7888

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.2

163.2

1755

4194

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

162.9

8769

32726

R13

ICD-10 Finland

Dysphagia

2.0

162.3

2177

5666

D09

ICPC

Nausea

2.0

162.2

2058

5248

R07

ICPC

Sneezing/nasal congestion

1.8

162.1

2892

8286

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

161.6

1791

4332

M70.7

ICD-10 Finland

Other bursitis of hip

3.7

161.2

660

920

R06AX13

ATC

loratadine; oral

1.5

161.0

6082

21161

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.1

160.5

833

1369

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

159.6

1721

4117

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

159.2

1103

2145

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

158.6

3823

11945

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

158.4

2835

8130

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

158.2

3314

9960

H92.0

ICD-10 Finland

Otalgia

1.9

158.2

2401

6526

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

158.1

2476

6801

B02AA02

ATC

tranexamic acid; systemic

1.5

158.1

5326

18066

I20.09

ICD-10 Finland

Unstable angina

2.2

158.0

1647

3885

N06AX05

ATC

trazodone; oral

2.9

157.9

927

1643

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

157.6

4347

14062

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

157.6

2220

5880

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

157.5

1372

2990

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

157.1

8164

30252

RD211, ,

NOMESCO Finland

2.3

157.0

1394

3065

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

156.9

11897

47012

-50

ICPC

Medication/prescr/renewal

2.4

156.8

1303

2777

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

156.4

3156

9382

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

156.3

3908

12328

U05

ICPC

Urination problems other

2.3

156.2

1474

3331

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.1

155.8

802

1311

N06AX22

ATC

agomelatine; oral

2.8

155.6

987

1829

L10

ICPC

Elbow symptom/complaint

2.0

155.3

2029

5229

EMB10

NOMESCO Finland

Tonsillectomy

1.8

155.3

2746

7844

G04CB01

ATC

finasteride; oral

1.7

155.1

3620

11211

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

154.8

2774

7956

N06AA10

ATC

nortriptyline; systemic

3.5

154.5

684

1010

N02CC06

ATC

eletriptan; oral

2.3

154.4

1386

3062

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

154.1

1735

4223

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.9

153.9

908

1614

K07.60

ICD-10 Finland

Snapping jaw

2.0

152.5

2014

5210

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.1

152.3

1690

4089

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.3

151.9

1352

2975

B01AB04

ATC

dalteparin; parenteral

2.1

151.9

1645

3941

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.5

151.6

1151

2347

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

151.6

3222

9721

A97

ICPC

No disease

1.5

151.5

6937

25078

XQ800

NOMESCO Finland

Prick test

1.8

151.2

2912

8536

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

151.1

2609

7395

L20

ICPC

Joint symptom/complaint NOS

2.4

151.1

1246

2646

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005719) IgG [Mass/volume] in Serum or Plasma

4512

12003

1.99

323.31

2.6

10.38

10.95

g/l

12.74

4151

10966

(3000494) Fungus identified in Specimen by Culture

6217

18465

1.80

320.02

1.5

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4343

11503

1.99

314.56

2.8

2.2

70.41

71.95

ml/min/173m2

1.23

1761

3979

(3019225) pH of Specimen

4828

13292

1.92

313.47

4.5

3.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3466

8431

2.16

312.79

8.0

7.2

24.68

24.70

mmol/l

0.14

3446

8348

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3953

10151

2.05

310.96

3.0

2.5

200.88

195.54

ng/l

0.25

3531

9120

(3018418) pH of Serum or Plasma

15031

42257

2.10

307.65

4.5

3.5

7.40

0.66

3197

7444

(3024354) Oxygen [Partial pressure] in Venous blood

4121

10373

2.09

307.65

4.0

3.0

4.76

4.68

kpa

1.05

3962

9995

(3021589) Normoblasts [#/volume] in Blood

22983

81072

1.75

307.65

10.8

7.3

0.00

e9/l

0.19

19053

65577

(3013512) EKG study

13720

42400

1.85

307.65

3.8

3.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

30789

100206

2.27

307.65

9.9

8.0

4.22

3.94

e9/l

66.38

27252

86549

(3019060) Gas panel - Arterial blood

3614

6978

2.74

307.65

5.2

4.6

—

(3044640) Blood type and Crossmatch panel - Blood

17804

46702

2.38

307.65

2.5

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

19482

62150

1.91

307.65

2.0

1.7

95.39

97.02

pmol/l

4.39

10872

32231

(40768797) Stomach Pathology biopsy report

7217

19566

2.00

307.65

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

17807

45811

2.43

307.65

2.9

2.2

63.70

60.81

u/l

0.27

16618

42141

(3006315) Basophils [#/volume] in Blood

27057

86735

2.14

307.65

6.6

5.3

0.04

e9/l

6.62

23809

74989

(3019150) Specific gravity of Urine by Refractometry

12322

34875

2.02

307.65

4.1

2.8

1.02

kg/l

0.20

1663

5625

(36304419) Bacteria [Presence] in Urine

14625

41718

2.06

307.65

3.3

2.5

—

(3006504) Eosinophils/100 leukocytes in Blood

25072

83051

1.97

307.65

6.8

5.4

2.80

2.88

6.78

23540

77890

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5707

12974

2.37

307.65

3.6

2.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

49930

198261

4.05

307.65

16.9

8.6

22.89

23.00

mg/l

0.26

42348

142378

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

38376

146649

2.08

307.65

4.2

3.5

14.69

14.54

pmol/l

26.63

35471

133607

(3025159) Blasts/100 leukocytes in Blood

4320

11305

2.02

307.65

4.4

4.1

0.17

0.30

0.70

1203

2656

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3103

6865

2.37

307.65

1.7

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

26418

74158

2.55

307.65

2.8

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

15016

42075

2.11

307.65

4.2

2.9

0.00

estimate

0.05

5342

14475

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19877

52338

2.45

307.65

3.7

2.5

91.79

62.29

ng/l

0.50

12511

29888

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

45191

199288

1.84

307.65

4.3

3.6

4.59

4.76

mmol/l

244.48

42515

187516

(3048689) Calprotectin [Mass/mass] in Stool

7808

22414

1.89

307.65

2.7

2.4

132.11

123.31

ug/g

1.19

6242

17752

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

50397

218519

3.05

307.65

11.7

7.5

27.84

27.16

u/l

7.07

49059

210323

(3007461) Platelets [#/volume] in Blood

52378

237081

3.59

307.65

24.7

13.0

255.67

251.01

e9/l

47.32

51535

229350

(3009343) pH of Capillary blood

3573

7733

2.43

307.65

3.7

3.1

7.41

7.42

4.44

499

917

(3043409) Potassium [Moles/volume] in Arterial blood

1761

2932

3.11

307.65

4.4

4.3

3.88

mmol/l

0.06

1744

2893

(3042936) Bacteria identified in Isolate by Culture

8606

17899

2.70

307.65

2.2

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9617

23431

2.31

307.65

1.3

1.2

8.86

12.09

u/ml

3.40

3973

9183

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16059

41354

2.37

307.65

2.3

1.9

223.45

221.21

u/l

0.06

15211

38823

(3035941) MCH [Entitic mass]

52394

237403

3.58

307.65

24.6

13.0

30.22

30.19

2.55

51918

233360

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

27829

79490

2.57

307.65

6.3

5.5

10.64

12.15

umol/l

61.74

26390

74909

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

45864

201858

1.92

307.65

4.7

3.9

2.74

2.87

mmol/l

171.99

42936

188930

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8878

24943

1.96

307.65

3.1

2.8

2.44

2.43

mmol/l

4.51

7761

21560

(3002385) Erythrocyte distribution width [Ratio]

41775

180745

1.71

307.65

19.4

11.1

14.87

14.74

0.44

41213

176577

(3026361) Erythrocytes [#/volume] in Blood

52403

237480

3.59

307.65

24.7

13.0

4.52

4.59

e12/l

214.55

51452

229113

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7234

17592

2.25

307.65

6.9

5.6

1.05

1.04

mmol/l

2.19

6794

16382

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

12753

42619

1.67

307.65

1.3

1.39

1.99

u/ml

6.21

3639

11385

(3031040) Bacteria [#/volume] in Urine by Automated count

34493

112664

2.48

307.65

4.7

3.2

1277.74

1083.11

e6/l

0.29

548

1402

(3018405) Lactate [Moles/volume] in Arterial blood

2046

3455

3.08

307.65

4.2

4.0

1.39

1.44

mmol/l

0.94

2019

3365

(3017143) Hepatitis C virus Ab [Presence] in Serum

8181

25756

1.72

307.65

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6096

13421

2.46

307.65

1.8

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

16816

49750

2.03

307.65

3.4

3.0

2.35

mmol/l

8.08

15100

43971

(3004588) Protein electrophoresis panel - Serum or Plasma

3273

7430

2.31

307.65

2.3

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

25593

80885

2.13

307.65

7.2

5.7

—

(40758558) Short blood count panel - Blood

13412

42256

1.80

307.65

7.3

6.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

9281

23114

2.24

307.65

1.8

1.6

1191.48

1106.79

nmol/l

12.71

7253

17186

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3497

6740

2.74

307.65

7.5

6.6

24.52

24.41

mmol/l

0.74

3336

6338

(3010813) Leukocytes [#/volume] in Blood

52404

237514

3.59

307.65

24.7

13.0

6.96

6.54

e9/l

274.89

51456

229083

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8753

22073

2.20

307.65

3.8

3.3

0.82

0.83

mmol/l

12.63

8259

20663

(3022096) Basophils/100 leukocytes in Blood

24273

80266

1.95

307.65

6.8

5.5

0.66

0.68

10.27

22721

74985

(3022217) INR in Platelet poor plasma by Coagulation assay

24248

63673

2.66

307.65

14.2

10.1

1.23

1.20

inr

5.57

7677

18264

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

44606

179948

2.36

307.65

5.0

4.0

2.07

2.17

mu/l

0.38

41593

166247

(3017181) Myelocytes/100 leukocytes in Blood

4789

12395

2.05

307.65

4.3

4.0

0.91

0.06

1656

3660

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8299

21593

2.12

307.65

2.3

2.1

29.84

29.77

0.47

8043

20986

(3019198) Lymphocytes [#/volume] in Blood

27788

90427

2.13

307.65

6.6

5.3

1.94

1.96

e9/l

0.94

24994

80113

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

35112

150697

1.50

307.65

3.6

3.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

22563

63657

2.35

307.65

5.4

4.3

35.80

36.36

g/l

35.12

21129

58759

(3020682) Albumin/Creatinine [Ratio] in Urine

14141

44833

1.81

307.65

4.1

3.7

11.94

7.93

mg/mmol

11.44

9405

28756

(3026493) Urate [Moles/volume] in Serum or Plasma

14123

39307

2.10

307.65

2.7

2.3

3341.76

5171.18

umol/l

5.83

12500

35309

(3020891) Body temperature

2317

4074

2.96

307.65

5.2

4.4

—

(3001604) Monocytes [#/volume] in Blood

26987

86557

2.14

307.65

6.6

5.3

0.59

0.56

e9/l

31.71

23771

74909

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6029

15684

2.06

307.65

4.3

4.2

235.25

245.79

u/l

4.10

5694

14902

(3002179) Metamyelocytes/100 leukocytes in Blood

4398

11291

2.06

307.65

4.1

3.8

0.62

0.68

0.83

1458

3158

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

13207

32840

2.37

307.65

3.2

2.6

1500.25

1238.18

ng/l

5.80

11085

27251

(3003694) ABO and Rh group [Type] in Blood

15905

57591

1.56

307.65

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

42571

172182

2.12

307.65

5.7

4.4

39.54

38.43

mmol/mol

91.53

39958

160378

(3041096) Erythrocytes [Presence] in Urine by Automated

14610

49605

1.67

307.65

3.4

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13601

34773

2.30

307.65

2.5

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

52364

236738

3.61

307.65

24.8

13.1

40.44

41.16

7.57

49740

222257

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5141

10888

2.54

307.65

8.8

8.6

122.84

123.68

g/l

1.66

5011

10555

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8385

24839

1.84

307.65

3.1

2.4

2.64

2.68

e6/l

0.09

4521

13060

(3030467) Casts [#/volume] in Urine by Automated count

14919

42177

2.09

307.65

3.4

2.6

0.35

0.39

e6/l

1.06

11647

30417

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2204

4010

2.86

307.65

2.0

1.9

2.41

2.01

ug/l

0.55

1958

3567

(3033658) Prothrombin time (PT) actual/Normal

13739

40797

1.94

307.65

4.3

3.6

91.47

90.93

1.50

13352

39782

(3002032) Base excess in Venous blood by calculation

5037

12513

2.14

307.65

4.7

3.6

1.78

1.74

mmol/l

0.30

4252

10520

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7910

20529

2.11

307.65

2.7

2.2

2.35

2.37

g/l

1.72

7365

19035

(3026782) Osmolality of Urine

10911

30029

2.05

307.65

3.1

2.4

544.45

566.05

mosm/kgh2o

11.89

9526

25322

(3026008) Bacteria identified in Urine by Culture

15598

41914

2.24

307.65

3.1

2.3

—

(40768804) Tissue Pathology biopsy report

19669

72208

1.59

307.65

2.1

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

8566

22437

2.11

307.65

2.7

2.2

13.19

14.50

umol/l

38.19

8033

21038

(3013115) Eosinophils [#/volume] in Blood

27883

89993

2.16

307.65

6.9

5.6

0.19

e9/l

2.99

24885

78896

(3021960) Folate [Moles/volume] in Serum or Plasma

11359

31375

2.05

307.65

1.6

1.4

19.67

20.27

nmol/l

3.44

9968

27215

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7391

18901

2.13

307.65

2.8

2.3

22.73

24.79

22.40

6369

16373

(3021601) Nitrite [Presence] in Urine by Test strip

26238

85046

2.08

307.65

5.1

3.8

0.00

estimate

1.83

5571

15150

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5291

14458

1.95

307.65

2.8

2.2

49.24

42.42

u/l

0.30

4550

12464

(3023368) Bacteria identified in Blood by Culture

15257

34241

2.74

307.65

4.6

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4328

11032

2.07

307.65

4.2

3.2

1.22

1.23

mmol/l

2.51

3837

9528

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4960

13399

1.96

307.65

2.3

2.6

0.22

g/l

1.00

4631

12421

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4259

8530

2.66

307.65

1.7

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

6174

13392

2.50

307.65

7.8

7.6

12.46

13.08

kpa

11.62

5899

12717

(3018010) Neutrophils/100 leukocytes in Blood

25554

86002

1.95

307.65

6.6

5.2

57.40

56.21

45.50

24053

81077

(3002030) Lymphocytes/100 leukocytes in Blood

25916

87422

1.95

307.65

6.8

5.4

27.97

29.26

62.56

24422

82441

(3020779) Urea [Moles/volume] in Serum or Plasma

4934

11781

2.23

307.65

8.7

7.1

9.53

8.92

mmol/l

6.15

4713

11210

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3789

8965

2.23

307.65

4.3

3.9

95.29

85.71

ng/l

5.30

3321

7891

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

12566

42662

1.64

307.65

1.8

1.5

—

(3024731) MCV [Entitic volume]

52398

237440

3.59

307.65

24.6

13.0

90.62

90.22

69.94

51922

233381

(3002582) Erythrocytes [#/volume] in Urine

16385

46601

2.11

307.65

3.5

2.6

83.35

93.67

e6/l

0.31

12894

34232

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

44828

197920

1.80

307.65

4.3

3.6

1.39

1.47

mmol/l

307.65

41991

185731

(3001122) Ferritin [Mass/volume] in Serum or Plasma

23890

82483

1.83

307.65

3.2

2.6

118.20

109.56

ug/l

4.23

22352

77474

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9053

25466

1.96

307.65

2.9

2.4

1.07

1.00

e6/l

0.58

5171

13653

(3027945) Reticulocytes/100 erythrocytes in Blood

5736

14267

2.16

307.65

2.8

2.6

1.79

1.67

12.71

5084

12720

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3470

7147

2.56

307.65

9.8

10.2

1.43

1.32

6.24

3445

7096

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3474

7163

2.56

307.65

9.8

10.4

0.68

0.66

3.39

3448

7115

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

39249

131585

2.79

307.65

8.2

6.0

76.88

76.64

u/l

0.38

37340

123189

(3016502) Oxygen saturation in Arterial blood

5573

11664

2.58

307.65

8.3

8.2

95.70

95.89

1.06

5364

11186

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9738

27686

1.95

307.65

3.9

2.9

348.36

704.12

ng/l

8.20

6864

19495

(3012544) pH of Venous blood

5234

12889

2.17

307.65

4.6

3.6

7.37

7.38

0.56

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3451

7490

2.42

307.65

3.7

3.1

1.52

1.47

mmol/l

0.27

2507

5385

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

43417

190464

1.74

307.65

3.9

3.3

1.37

1.23

mmol/l

180.85

40445

177804

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10572

30406

1.94

307.65

1.7

1.5

30421134.62

32359356.15

pmol/l

0.12

8961

25554

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4537

9293

2.61

307.65

2.5

1.9

6.74

8.85

ug/l

6.02

3952

8192

(3007853) Bacteria identified in Skin by Aerobe culture

7474

15777

2.62

307.65

1.9

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6300

17991

1.87

307.65

2.8

7.36

9.57

umol/l

10.36

5410

15708

(3037467) Urinalysis macro (dipstick) panel - Urine

35427

123035

2.29

307.65

4.6

3.3

—

(3003396) Base excess in Arterial blood by calculation

6189

13384

2.51

307.65

7.9

7.6

1.02

0.80

mmol/l

3.39

4828

10513

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

45189

185543

2.32

307.65

14.7

8.4

87.36

87.20

ml/min/173m2

0.69

38283

146469

(3021440) Promyelocytes/100 leukocytes in Blood

4553

11881

2.03

307.65

4.4

4.1

0.11

0.08

1428

3165

(40761511) CBC panel - Blood by Automated count

50058

215539

3.00

307.65

15.5

8.3

—

(3023520) Reticulocytes [#/volume] in Blood

4248

9859

2.28

307.65

2.7

2.6

71.52

68.08

e9/l

5.97

3202

7241

(3013826) Glucose [Moles/volume] in Serum or Plasma

30975

93550

2.55

307.65

5.3

3.9

6.63

6.61

mmol/l

0.87

29137

84628

(3014007) Fractional oxyhemoglobin in Arterial blood

3474

7167

2.55

307.65

9.9

10.4

93.87

94.09

1.06

3460

7135

(3014111) Lactate [Moles/volume] in Serum or Plasma

4988

11244

2.37

307.65

7.6

7.3

1.35

1.40

mmol/l

1.83

4849

10948

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

13876

36015

2.27

307.65

2.3

2.0

2.92

2.73

mg/l

15.90

12020

30457

(40761535) Cells panel - Urine sediment

4694

9757

2.57

307.65

3.6

2.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4073

9543

2.26

307.65

2.6

2.2

66.51

66.93

g/l

2.43

3746

8756

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

22887

64998

2.34

307.65

6.7

5.1

1.21

mmol/l

21.24

21149

58902

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3637

7807

2.46

307.65

3.7

3.1

5.14

5.13

kpa

0.25

3474

7365

(3000850) Epithelial cells [#/volume] in Urine

11950

29924

2.31

307.65

2.8

2.2

5.63

5.59

e6/l

0.10

10849

26255

(3035350) Ketones [Presence] in Urine by Test strip

26345

84784

2.10

307.65

3.9

2.7

0.00

estimate

0.00

5748

15766

(3015736) pH of Urine

21631

68552

1.99

307.65

3.5

2.5

5.88

5.90

0.30

1707

6973

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6164

13538

2.47

307.65

1.8

1.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6799

15996

2.32

307.65

8.0

6.9

104.51

104.69

mmol/l

2.00

6793

15975

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3519

7295

2.54

307.65

1.5

1.4

—

(3012516) Albumin [Mass/volume] in Urine

13523

42348

1.82

307.65

3.5

3.1

443.02

349.79

mg/l

1.34

9125

26950

(3011397) Hemoglobin [Presence] in Urine by Test strip

12601

36575

1.97

307.65

3.8

2.7

—

(3044889) 12 lead EKG panel

33677

122625

2.01

307.65

3.8

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6583

16383

2.18

307.65

7.2

4.7

—

(3000991) Gas panel - Venous blood

4664

11193

2.21

307.65

9.4

8.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

12822

32883

2.27

307.65

1.9

1.7

1.06

1.22

mg/l

5.52

9608

24180

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

20689

66075

1.94

307.65

4.0

2.7

—

(3037522) Nuclear Ab [Titer] in Serum

8058

22149

1.99

307.65

1.4

1.3

515.01

556.29

titre

0.90

1500

4232

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5667

13392

2.28

307.65

2.2

2.1

366.63

391.74

nmol/l

13.57

5218

12391

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9052

19865

2.57

307.65

1.9

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6175

13402

2.50

307.65

7.9

7.6

5.09

5.04

kpa

2.92

5899

12736

(3000963) Hemoglobin [Mass/volume] in Blood

52408

237613

3.58

307.65

24.8

13.1

135.58

138.12

g/l

265.54

51926

233596

(3013707) Erythrocyte sedimentation rate by Westergren method

38141

129217

2.62

307.65

4.4

3.1

11.38

9.76

mm/h

85.48

35761

119334

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

24991

72904

2.35

307.65

7.5

5.5

1.21

1.22

mmol/l

26.38

21272

61761

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

34537

137867

1.73

307.65

3.5

2.6

48.83

41.46

u/l

40.80

32628

130342

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

20830

68144

1.88

307.65

2.4

2.1

74.06

1390.48

nmol/l

0.50

19060

62339

(3007164) IgA [Mass/volume] in Serum or Plasma

11220

36942

1.68

307.65

1.5

1.4

2.33

2.31

g/l

0.41

7178

23135

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

44948

187837

2.17

307.65

4.5

3.6

5.93

5.75

mmol/l

121.56

41585

173401

(3019069) Monocytes/100 leukocytes in Blood

25208

83575

1.98

307.65

7.1

5.6

8.42

8.47

1.48

23714

78486

(3009261) Glucose [Presence] in Urine by Test strip

26480

85858

2.09

307.65

3.9

2.7

0.00

estimate

0.69

5372

14671

(3009508) Creatinine [Moles/volume] in Urine

15622

49320

1.85

307.65

3.5

3.0

7.98

8.66

mmol/l

1.67

13503

42418

(3020564) Creatinine [Moles/volume] in Serum or Plasma

50596

215711

3.40

307.65

18.5

10.0

77.58

75.38

umol/l

33.74

50587

215589

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5034

12578

2.13

307.65

4.7

3.6

5.85

5.82

kpa

0.99

4857

12176

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18111

59132

1.82

307.65

3.4

3.0

33.13

33.58

u/l

0.18

17203

56228

(3023103) Potassium [Moles/volume] in Serum or Plasma

49562

198845

3.70

307.65

18.2

9.9

3.96

3.94

mmol/l

39.30

48595

191339

(3018095) Leukocytes [#/volume] in Urine

18971

56770

2.06

307.65

4.0

3.0

82.32

86.71

e6/l

0.25

13884

37085

(3019550) Sodium [Moles/volume] in Serum or Plasma

49470

197968

3.69

307.65

18.1

9.8

139.53

139.75

mmol/l

75.38

48576

191012

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10136

25609

2.23

307.65

1.3

1.2

29.09

34.13

iu/ml

0.89

3104

8181

(3002256) Pathology report gross observation

6740

20761

1.73

305.88

1.3

1.2

—

(3022145) Colonoscopy Study observation

5930

17656

1.79

301.57

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3227

7810

2.16

294.28

3.9

2.9

129.40

133.12

g/l

13.72

3142

7646

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1568

2638

3.07

291.87

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1422

2257

3.25

289.61

1.7

1.5

14722.51

12407.25

e6/l

0.66

1034

1623

(40761536) Microorganisms panel - Urine sediment

4961

14138

1.85

289.31

4.1

2.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2912

6806

2.23

288.33

10.8

10.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2589

5747

2.35

287.82

3.6

2.6

1.41

1.23

8.46

2576

5716

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1852

3504

2.74

282.43

1.8

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2048

4134

2.57

276.58

2.5

2.3

553.69

602.43

ug/l

0.15

1915

3810

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

15135

57579

1.46

276.57

4.6

4.3

3.17

3.04

ug/l

0.14

13605

52152

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1169

1673

3.60

275.92

1.7

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2521

5642

2.32

275.03

3.5

2.6

0.66

0.65

0.15

2510

5618

(3022313) Gas panel - Capillary blood

2517

5674

2.31

270.14

3.8

3.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3766

10010

1.97

268.41

2.5

2.3

6128.42

6458.31

u/l

0.21

1409

4183

(4200892) Spirometry reversibility

3785

10111

1.96

265.92

1.4

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1627

2962

2.84

265.42

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2375

5291

2.33

261.46

2.0

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2775

6698

2.16

253.73

10.4

10.1

24.13

24.19

mmol/l

0.45

2677

6482

(3025941) Bacteria identified in Stool by Culture

3600

9627

1.96

251.67

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2438

5599

2.26

250.57

1.8

1.53

1.38

g/l

9.21

2102

4776

(3003338) MCHC [Mass/volume]

41068

187777

1.43

247.71

20.9

11.2

332.90

333.73

g/l

57.94

40752

186038

(3028026) IgM [Mass/volume] in Serum or Plasma

3493

9293

1.97

247.60

1.8

1.29

1.34

g/l

0.53

3229

8516

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1563

2907

2.77

245.42

3.3

2.7

24.38

24.53

mmol/l

0.62

1536

2830

(3005322) IgE [Units/volume] in Serum or Plasma

3978

11129

1.87

243.48

1.3

232.26

294.87

u/ml

2.21

3688

10307

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2166

4799

2.34

240.99

1.9

1.6

—

(3008898) HLA-B27 [Presence]

2568

6148

2.17

239.17

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8040

27512

1.56

237.38

2.0

1.7

1.48

1.36

30.77

7139

24862

(3017732) Neutrophils [#/volume] in Blood

4006

11352

1.85

235.45

2.8

2.5

5.08

4.57

e9/l

1.19

3316

9506

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10776

39357

1.48

235.14

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2507

5999

2.17

233.66

4.0

3.0

25.06

25.23

mmol/l

1.50

2415

5811

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2967

7602

2.03

232.59

2.9

2.3

0.27

0.29

e6/l

0.35

2889

7349

(46235355) HIV 1 and 2 tests - Meaningful Use set

13074

49678

1.44

232.22

2.1

2.0

—

(3021788) Differential panel - Synovial fluid

1114

1741

3.29

231.89

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1867

3936

2.45

230.61

6.2

5.1

1.31

mmol/l

0.03

1645

3453

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2753

6908

2.07

227.80

5.1

4.0

24.06

24.03

mmol/l

0.16

2682

6738

(3010421) pH of Blood

1674

3367

2.57

227.10

4.4

3.3

7.42

1.23

1522

3048

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2376

5723

2.15

217.64

1.3

1.2

0.78

1.11

u/ml

0.67

218

364

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1776

3801

2.41

212.41

3.4

3.2

0.33

u/ml

0.01

1012

2065

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2312

5565

2.15

212.03

4.4

3.4

51.15

47.65

7.60

2283

5499

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2160

5059

2.21

211.48

3.9

3.3

24.65

24.66

mmol/l

0.09

2015

4713

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2118

4963

2.21

207.06

1.6

12.84

3.65

iu/ml

0.56

435

1030

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5208

16534

1.66

206.10

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

1464

2906

2.59

203.54

4.4

3.4

8.82

8.86

kpa

0.31

1442

2825

(3013290) Carbon dioxide [Partial pressure] in Blood

1454

2896

2.59

200.81

4.4

3.4

5.03

4.99

kpa

1.10

1432

2816

(3012501) Base excess in Blood by calculation

1453

2896

2.58

200.40

4.4

3.4

2.37

2.35

mmol/l

0.05

958

1908

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1656

3528

2.42

199.83

1.4

276.93

281.36

ug/g

0.31

922

1997

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1970

4552

2.24

198.87

1.8

1.7

1.19

1.14

g/l

10.15

1879

4329

(40767503) Oxygen content in Capillary blood by calculation

1323

2555

2.66

193.65

2.6

2.3

16.63

17.16

3.30

675

1252

(3028626) Oxygen [Partial pressure] in Capillary blood

1450

2943

2.54

192.98

3.3

3.1

8.46

8.64

kpa

2.98

1415

2855

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1911

4417

2.23

192.70

1.8

1.7

0.24

0.23

g/l

5.53

1818

4189

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1746

3878

2.32

192.63

2.6

2.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1420

2861

2.55

191.72

1.7

1.6

—

(1616796) Gas panel - Central venous blood

1400

2811

2.56

190.28

3.9

3.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

854

1298

3.37

185.06

6.9

6.2

11.11

10.87

mg/l

0.61

785

1195

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

8735

31903

1.46

184.68

2.3

2.0

—

(3000492) Spirometry study

5651

18792

1.58

184.56

1.4

—

(3044941) Cell count panel - Synovial fluid

928

1500

3.17

183.47

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

1131

2080

2.79

180.80

2.8

2.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2380

6181

1.99

178.82

1.5

1.6

13.58

11.42

u/ml

0.22

227

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1362

2798

2.50

176.86

1.7

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11922

46467

1.38

174.23

1.7

1.6

1.48

1.31

mmol/l

55.53

10156

40006

(3007930) Methemoglobin/Hemoglobin.total in Blood

2044

5072

2.08

173.14

5.9

4.4

0.91

0.90

0.27

1907

4746

(3037121) Protein [Mass/volume] in Urine

1939

4729

2.12

171.56

3.3

0.39

0.31

g/l

1.45

905

2288

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11782

45963

1.38

170.65

4.1

3.7

21.75

21.94

0.55

5250

20425

(3045414) Leukocytes [Presence] in Urine

2466

6604

1.93

169.85

1.9

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

770

1156

3.41

169.82

1.6

1.5

56.06

53.20

0.88

482

777

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2060

5166

2.06

169.76

5.8

4.4

1.78

1.65

3.83

1917

4832

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4371

13919

1.64

169.17

4.2

4.0

18.87

30.36

ug/l

1.56

3526

10884

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

9426

35505

1.42

166.89

2.4

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1861

4518

2.12

166.49

1.9

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1469

3265

2.31

161.56

3.3

2.9

56.61

44.80

mg/l

0.56

1189

2646

(3034860) Kappa light chains.free [Mass/volume] in Serum

1465

3273

2.30

159.26

3.3

2.9

48.71

56.74

mg/l

1.28

1180

2656

(3028707) Methadone [Presence] in Urine by Screen method

1815

4441

2.11

159.14

3.6

2.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1315

2802

2.41

158.34

1.4

1.3

—

(4035726) Immunohistochemistry procedure

4113

13111

1.64

158.04

1.4

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

1015

1914

2.72

155.08

2.0

1.8

1.73

1.82

mmol/l

1.33

995

1870

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1423

3187

2.30

153.81

3.3

2.9

2.98

3.02

ratio

0.01

130

235

(3023511) Choriogonadotropin [Units/volume] in Urine

1945

5017

2.00

148.42

1.5

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

7029

25619

1.45

146.71

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2576

7358

1.81

145.46

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

606

865

3.58

143.42

1.5

31.71

36.60

1.80

363

577

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1021

2014

2.60

143.42

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3522

11091

1.65

141.23

1.3

50.68

53.82

au/ml

0.29

169

611

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3795

12184

1.62

141.10

2.4

2.3

21.20

22.40

au/ml

0.30

297

1153

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1890

4924

1.98

140.23

2.9

2.7

3.60

3.53

g/l

1.16

1782

4697

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3469

10938

1.65

138.32

3.3

3.4

4.53

4.60

pmol/l

3.07

3110

9808

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1593

3915

2.09

137.92

1.4

1.3

488.09

515.54

mg/l

0.76

1514

3735

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1883

4929

1.97

137.86

1.6

284.16

360.28

titre

0.47

179

(3036489) Thrombin time

2220

6162

1.86

136.96

2.4

2.1

21.10

21.34

1.06

1874

5373

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1770

4542

2.01

136.84

2.4

1.9

7.45

7.10

g/l

11.88

1618

4140

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1767

4533

2.01

136.72

2.4

1.9

3.70

3.73

g/l

0.25

1616

4138

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1768

4537

2.01

136.68

2.4

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

1123

2382

2.42

136.43

3.4

3.0

—

(3022621) pH of Urine by Test strip

3354

10520

1.66

136.39

3.0

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3491

11091

1.63

135.06

1.2

—

(3039000) Anion gap in Blood

1209

2683

2.31

133.27

7.8

6.2

11.27

11.34

mmol/l

0.22

1079

2401

(3018572) Chloride [Moles/volume] in Blood

1209

2684

2.31

133.16

7.8

6.2

105.13

105.29

mmol/l

0.50

1079

2403

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1360

3202

2.18

130.83

6.2

5.1

1780.23

1028.28

iu/ml

0.29

198

421

(3022806) Fractional oxyhemoglobin in Capillary blood

838

1571

2.73

129.38

1.9

1.7

90.33

90.23

0.17

828

1544

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1306

3042

2.20

128.88

2.3

2.0

131.16

133.96

g/l

3.06

997

2178

(36660697) Celiac disease serology panel - Serum

4519

15428

1.53

128.78

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

1690

4359

1.99

128.77

3.1

2.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4750

16403

1.51

128.37

2.4

2.1

11.88

13.03

nmol/l

16.90

4283

15045

(3024928) Oxygen saturation in Venous blood

1229

2803

2.25

127.36

4.0

3.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1004

2087

2.46

127.14

1.5

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1412

3428

2.12

125.99

1.3

1.2

3.70

3.69

mmol/l

0.11

1324

3213

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1158

2585

2.30

125.96

1.5

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

562

837

3.43

125.42

1.4

99393.81

59247.62

e6/l

0.74

389

567

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

958

1960

2.50

125.27

1.3

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

829

1578

2.69

124.49

1.7

1.4

—

(3003181) Sodium [Moles/volume] in Urine

886

1749

2.59

124.26

1.4

64.29

65.75

mmol/l

0.36

706

1349

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1230

2840

2.22

123.87

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1230

2843

2.22

123.57

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1656

4305

1.98

123.44

2.4

1.9

2.98

2.87

g/l

3.68

1504

3905

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1324

3168

2.14

122.44

3.8

3.5

57.52

56.68

1.45

1324

3168

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1639

4267

1.98

121.66

2.4

1.9

10.12

10.54

g/l

2.91

1482

3849

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1450

3636

2.05

119.06

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5468

19733

1.45

118.21

4.2

3.8

31.34

32.11

5.39

4050

13656

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2296

6739

1.76

118.06

1.9

2.0

38.98

40.10

u/l

1.72

2083

6105

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1922

5345

1.85

117.62

2.5

2.3

93.59

91.80

2.62

1843

5134

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

967

2051

2.41

117.46

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

967

2052

2.41

117.34

1.7

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

864

1735

2.55

117.23

1.5

1.3

—

(3049717) Cytology report of Urine Cyto stain

1775

4817

1.90

116.94

2.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1737

4694

1.90

115.86

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1391

3483

2.05

114.62

1.5

1.4

24.66

29.71

e6/l

0.32

1084

2633

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1391

3487

2.05

114.28

1.5

1.4

3898.89

1200.65

e6/l

0.51

1143

2764

(3004809) Band form neutrophils/100 leukocytes in Blood

935

1989

2.41

112.87

3.2

1.42

1.66

0.99

826

1758

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1774

4886

1.87

111.75

3.0

2.5

181.21

178.93

0.46

1686

4645

(3009466) Valproate [Moles/volume] in Serum or Plasma

1008

2240

2.30

110.73

5.2

5.0

360.90

377.01

umol/l

2.35

883

1944

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1042

2362

2.26

109.46

3.7

2.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1494

3907

1.96

109.43

2.4

2.1

0.79

0.86

g/l

0.25

1298

3412

(3011288) Drugs identified in Urine by Screen method

2535

7821

1.67

109.03

4.2

2.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2417

7375

1.69

108.26

2.4

2.3

—

(4034850) Laboratory test

1756

4880

1.85

107.58

10.2

6.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

795

1599

2.54

107.54

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

786

1580

2.54

106.44

3.0

2.8

0.83

0.80

nmol/l

1.02

594

1161

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6007

22449

1.40

106.32

1.7

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2860

9182

1.61

105.33

1.1

235.00

179.18

titre

0.43

299

(42529406) Shigella sp [Presence] in Stool by Culture

1695

4696

1.85

104.80

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1687

4670

1.86

104.57

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1672

4636

1.85

103.11

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

964

2174

2.27

102.45

1.7

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1035

2407

2.20

102.45

3.2

2.9

2370.65

9383.58

u/ml

0.67

137

(3023183) Ammonium ion [Moles/volume] in Plasma

1218

3032

2.06

101.86

2.6

3.3

33.77

35.56

umol/l

1.08

1120

2761

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

739

1477

2.56

101.22

1.5

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2022

5984

1.74

100.82

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1080

2575

2.15

100.69

1.2

280.00

96.60

titre

0.75

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

392

530

3.77

99.83

2.8

2.1

149.77

140.63

umol/l

0.18

215

244

(1001926) Buprenorphine [Presence] in Urine by Screen method

2827

9187

1.59

98.90

2.9

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2297

7091

1.67

98.38

1.5

1.4

8.79

8.45

u/l

0.63

1922

5776

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3189

10676

1.54

98.18

1.1

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2099

6368

1.70

95.80

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

680

1346

2.58

94.92

1.7

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1517

4187

1.86

94.82

1.3

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2254

6993

1.66

94.68

2.0

1.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

812

1759

2.36

94.33

1.1

1.54

2.59

iu/ml

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1542

4290

1.84

94.04

1.3

1.2

29.51

43.52

u/ml

1.17

275

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1038

2506

2.12

93.83

1.6

—

(3023419) Bacteria identified in Sputum by Culture

765

1624

2.41

92.78

2.6

2.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1346

3595

1.92

92.76

2.2

1.9

37.57

38.44

g/l

4.67

1194

3188

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1437

3930

1.88

92.34

1.3

251.01

251.65

u/ml

0.03

900

2512

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

767

1644

2.38

91.15

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1436

3951

1.86

90.60

1.3

1.2

12.06

7.81

u/ml

1.04

230

584

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1334

3582

1.91

90.51

2.2

1.9

0.02

g/l

0.05

1229

3285

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5419

20419

1.38

90.31

2.2

2.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

352

474

3.78

90.17

2.2

24.65

25.26

umol/l

0.02

(3044290) Cell count panel - Cerebral spinal fluid

1278

3397

1.93

89.30

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1026

2516

2.09

89.17

1.6

1.7

0.72

0.85

g/l

2.67

773

1897

(3003327) Ova and parasites identified in Stool by Light microscopy

2094

6473

1.66

89.10

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

748

1608

2.38

88.35

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

742

1590

2.38

88.24

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

742

1592

2.38

88.01

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

747

1610

2.37

87.75

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

740

1588

2.38

87.74

1.5

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1412

3909

1.85

87.40

1.3

1.2

9.04

6.47

u/ml

0.36

153

387

(3024139) IgG subclass 3 [Mass/volume] in Serum

697

1457

2.44

87.30

1.4

1.3

0.39

0.40

g/l

0.26

487

972

(3027135) IgG subclass 1 [Mass/volume] in Serum

697

1459

2.44

87.06

1.4

1.3

6.62

7.11

g/l

2.08

488

971

(3028192) IgG subclass 2 [Mass/volume] in Serum

697

1459

2.44

87.06

1.4

1.3

2.93

3.08

g/l

1.18

488

975

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1098

2791

2.01

86.87

1.6

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3140

10758

1.51

86.64

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

678

1410

2.45

85.83

1.6

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

678

1411

2.45

85.71

1.6

1.4

—

(4062490) Immunoglobulin typing, IgG

694

1462

2.42

85.56

1.4

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

663

1379

2.45

83.92

1.6

1.4

1.43

1.37

promille

0.40

493

1089

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1230

3310

1.90

82.90

2.3

1.9

0.00

g/l

0.13

1129

3023

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1566

4565

1.76

82.05

2.1

1.8

196.17

200.76

pmol/l

0.77

1489

4366

(3000012) Reticulocyte production index

720

1589

2.31

80.36

2.1

—

(3016879) Cocaine [Presence] in Urine

3233

11316

1.48

80.25

2.8

1.8

—

(3036180) Methadone [Presence] in Urine

565

1110

2.60

80.08

2.9

2.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2289

7435

1.58

79.89

1.1

14.12

7.53

u/ml

0.24

106

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1210

3280

1.89

79.81

2.3

2.0

0.00

g/l

-0.00

1125

3022

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1575

4658

1.73

78.53

4.4

3.8

1.53

1.35

mg/l

12.30

1472

4351

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

471

847

2.83

78.42

1.7

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

675

1470

2.34

77.58

6.1

9.1

7.37

7.11

mmol/l

0.49

562

1184

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1449

4208

1.76

76.87

2.0

11.20

10.40

mg/l

1.16

1360

3955

(3034891) Synovial lining cells/100 cells in Synovial fluid

315

441

3.63

76.76

1.5

1.4

4.64

4.43

0.06

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

633

1345

2.40

76.69

1.6

1.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

805

1906

2.16

76.37

1.2

1.3

0.23

0.22

nmol/l

0.01

108

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

669

1464

2.33

76.09

1.2

32.33

26.85

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

3428

12259

1.44

76.08

2.8

1.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1385

3987

1.78

75.65

1.5

1.4

16.73

23.81

u/ml

1.25

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

505

967

2.66

75.15

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

505

967

2.66

75.15

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

505

967

2.66

75.15

1.6

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1390

4015

1.77

75.07

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

3449

12386

1.44

74.82

2.8

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4357

16310

1.38

74.72

2.0

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1216

3378

1.84

74.44

2.3

2.4

149.72

83.44

ug/min

3.36

759

2091

(3020876) Protein [Mass/time] in 24 hour Urine

609

1289

2.41

74.40

2.5

2.4

1.61

1.37

g/24h

0.85

328

669

(3017315) Amylase [Enzymatic activity/volume] in Urine

376

612

3.13

73.75

1.3

1.2

409.60

335.48

u/l

0.35

349

567

(3027008) Opiates [Presence] in Urine

3435

12368

1.43

73.43

2.7

1.8

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

666

1482

2.29

73.03

2.1

2.2

32.44

33.13

3.09

659

1474

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1437

4237

1.74

72.38

1.4

1.5

16.60

12.60

iu/ml

0.34

103

(3008295) Osmolality of Serum or Plasma

585

1231

2.42

72.35

1.5

1.7

281.02

283.52

mosm/kgh2o

1.43

462

972

(3024263) Appearance of Synovial fluid

331

502

3.35

72.19

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1144

3151

1.86

71.90

1.3

1.2

5.99

6.66

u/ml

0.08

242

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1128

3103

1.86

71.17

1.2

30.08

10.44

u/ml

0.73

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

571

1201

2.42

70.70

1.7

1.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

795

1933

2.10

70.65

1.2

1.3

0.57

1.49

nmol/l

0.84

759

1873

(3019977) pH of Arterial blood

341

536

3.24

70.57

3.2

2.4

7.43

7.42

0.24

109

172

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3867

14322

1.40

70.46

1.2

134.59

155.04

iu/ml

1.93

1447

5382

(3026389) Candida sp identified in Specimen by Organism specific culture

869

2190

2.03

70.38

1.4

1.2

—

(3027944) Amphetamines [Presence] in Urine

3376

12212

1.43

70.28

2.6

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

555

1156

2.45

70.12

3.0

3.3

56.77

55.28

0.75

476

950

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1054

2851

1.89

69.97

1.4

1.3

21.17

22.77

u/l

0.85

888

2366

(3045424) Erythrocytes [Presence] in Urine

937

2448

1.96

68.78

1.5

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

775

1889

2.09

68.46

1.6

1.5

—

(3011412) CD3 cells [#/volume] in Blood

648

1476

2.24

67.42

2.5

1.24

1.19

e9/l

0.66

558

1310

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

531

1104

2.45

67.36

2.8

2.7

—

(3004616) Nuclear Ab [Presence] in Serum

704

1663

2.16

67.21

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

605

1339

2.30

67.18

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

276

389

3.61

66.73

2.5

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

592

1303

2.32

66.55

3.5

3.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

720

1726

2.13

66.32

1.2

1.3

—

(3011648) Oxygen content in Venous blood

504

1033

2.49

65.83

3.8

2.6

11.15

11.59

1.29

504

1033

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2308

7847

1.51

65.62

1.3

230.43

229.56

miu/ml

0.04

1072

3770

(3014051) Protein [Presence] in Urine by Test strip

1340

3992

1.72

65.09

2.6

2.1

—

(3042631) Mycobacterium sp identified in Specimen

669

1572

2.17

64.71

2.7

2.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2335

7997

1.50

64.11

3.1

2.7

44.33

47.66

u/ml

0.23

2261

7724

(40768443) Skin Pathology biopsy report

2133

7174

1.53

63.72

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2111

7089

1.53

63.51

1.9

1.7

36.96

41.58

nmol/l

15.06

2048

6965

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

835

2159

1.97

63.12

1.3

1.2

39.16

31.96

u/l

0.61

732

1874

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

509

1078

2.41

62.19

2.4

2.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

791

2019

2.00

61.95

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

537

1172

2.33

61.53

2.4

2.0

74.24

72.56

1.52

514

1131

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

973

2686

1.85

60.76

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

645

1533

2.14

60.72

1.5

1.4

33.16

33.20

g/l

0.03

584

1370

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

529

1158

2.33

60.23

2.4

2.0

13.44

14.90

2.51

512

1129

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1261

3775

1.71

60.20

1.6

1.4

115.41

105.14

u/ml

1.33

271

742

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8227

34531

1.24

60.03

2.8

0.74

0.77

ug/l

1.21

5273

20993

(21494890) Protein electrophoresis panel - 24 hour Urine

496

1065

2.37

58.90

2.1

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1567

5000

1.60

58.69

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

522

1151

2.31

58.51

1.3

1.2

1.96

2.00

mmol/l

0.31

486

1072

(3044242) Glucose [Moles/volume] in Arterial blood

289

464

3.17

58.03

2.5

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1002

2841

1.80

57.53

1.3

1.2

3.33

3.73

u/ml

0.27

340

1027

(3007566) Smooth muscle Ab [Titer] in Serum

1593

5130

1.59

57.44

1.2

1.3

78.41

132.22

titre

2.79

151

474

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1148

3395

1.73

57.22

1.3

1.2

41.40

44.61

u/ml

0.23

119

273

(3021387) Prolactin [Units/volume] in Serum or Plasma

2616

9368

1.44

57.21

1.7

1.6

307.03

318.24

mu/l

0.63

2369

8443

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

544

1236

2.24

57.01

1.4

1.3

1.44

1.31

nmol/l

1.74

489

1127

(3042517) Benzodiazepines panel - Urine

177

197

4.56

56.99

2.8

2.7

—

(3044927) Protein electrophoresis panel - Urine

458

962

2.42

56.98

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

972

2740

1.81

56.86

1.3

1.2

4.00

3.74

u/ml

0.24

434

1313

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

613

1467

2.13

56.77

2.1

1.7

24.88

27.58

mg/l

0.48

173

384

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

935

2611

1.83

56.36

1.1

116.55

115.03

0.74

854

2382

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

505

1117

2.30

56.24

1.6

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

1548

4993

1.59

55.45

1.2

1.3

899.17

1054.15

titre

0.33

142

(3023323) Follitropin [Units/volume] in Serum or Plasma

2940

10838

1.40

54.61

1.4

1.3

23.12

25.51

iu/l

3.61

2506

9320

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1666

5491

1.55

54.42

1.4

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

194

245

4.02

54.08

1.3

1.4

53.15

54.04

0.09

159

220

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

347

650

2.72

53.93

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

341

636

2.73

53.42

1.4

—

(3011985) Renin [Units/volume] in Plasma

749

1981

1.93

53.18

1.5

1.6

55.91

71.39

mu/l

1.35

659

1801

(3026470) Cobalt [Mass/volume] in Blood

278

461

3.07

53.13

2.0

3.18

3.52

ug/l

0.26

247

420

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

964

2775

1.77

52.69

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

786

2121

1.89

52.63

1.7

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

706

1836

1.96

52.59

1.4

461.74

409.44

pmol/l

0.13

599

1615

(1002224) Polysomnography panel

2430

8717

1.43

52.58

1.1

—

(3025577) Chromium [Mass/volume] in Blood

274

454

3.07

52.44

2.0

2.1

2.11

2.49

ug/l

0.57

227

380

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1191

3658

1.66

51.78

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

487

1102

2.25

51.57

1.4

1.3

6.26

6.18

mmol/l

0.19

456

1018

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1363

4340

1.61

51.48

1.9

2.0

3.96

17.83

iu/l

0.62

509

1709

(3000330) Specific gravity of Urine by Test strip

2247

7982

1.44

51.21

3.6

2.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

338

654

2.63

49.54

2.4

2.9

168.34

120.43

au/ml

0.67

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

482

1106

2.22

49.45

2.6

515.21

507.86

e6/l

0.10

388

924

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

471

1074

2.23

49.04

2.6

2.7

0.21

0.23

e9/l

1.76

385

920

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

479

1104

2.21

48.65

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

688

1824

1.92

48.56

1.4

—

(40768446) Kidney Pathology biopsy report

312

585

2.71

48.47

1.8

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

376

780

2.45

48.09

1.6

1.4

6.21

5.92

u/l

0.20

317

665

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

983

2933

1.71

47.54

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

474

1099

2.20

47.48

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

445

1007

2.25

47.17

1.1

1.2

1.05

1.06

ratio

1.23

144

372

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

352

714

2.51

47.12

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

316

607

2.65

46.98

1.7

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

316

608

2.64

46.84

1.7

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

673

1794

1.91

46.77

1.6

1.5

29.49

34.61

iu/ml

0.38

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

356

731

2.48

46.51

3.1

3.4

7.69

8.59

mg/l

1.56

285

596

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

389

835

2.37

46.35

1.7

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1070

3295

1.66

46.09

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

910

2680

1.73

46.08

3.8

3.5

534.68

915.05

u/ml

0.61

842

2430

(3038026) Centromere Ab [Units/volume] in Serum

444

1015

2.23

45.99

1.2

24.39

54.52

u/ml

1.55

(3014271) Vancomycin [Susceptibility]

240

398

3.06

45.95

2.9

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2092

7484

1.43

45.87

1.4

—

(3004451) EKG impression Narrative

263

462

2.89

45.83

1.3

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

443

1017

2.22

45.45

1.3

369.16

486.47

u/l

1.39

422

969

(3010838) Calcium [Moles/time] in 24 hour Urine

875

2560

1.74

45.33

1.9

2.0

5.18

5.44

mmol/24h

1.26

776

2309

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

681

1845

1.88

45.13

1.1

63.78

70.97

au/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

434

992

2.23

44.99

1.2

36.87

44.67

u/ml

0.26

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

432

989

2.22

44.62

1.2

81.63

48.56

u/ml

1.22

(3026250) Tacrolimus [Mass/volume] in Blood

347

720

2.45

44.41

38.7

33.6

7.57

7.21

ug/l

2.13

324

655

(40768806) Pleura Pathology biopsy report

507

1243

2.08

44.31

1.6

1.5

—

(3016038) Potassium [Moles/volume] in Urine

346

718

2.45

44.28

1.2

1.5

34.02

36.13

mmol/l

0.78

294

641

(3023199) Leukocytes [#/volume] in Pleural fluid

559

1423

2.00

44.25

1.5

1.4

2930.03

2642.27

e6/l

0.22

396

1015

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

419

951

2.24

44.16

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

207

321

3.28

43.94

1.8

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

231

386

3.04

43.72

6.7

5.8

24.74

24.76

mmol/l

0.02

214

351

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

357

759

2.39

43.45

1.9

136.78

139.26

0.21

336

713

(3002523) Influenza virus A Ag [Presence] in Specimen

1136

3615

1.60

43.04

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

482

1174

2.09

42.86

3.5

2.8

29.04

25.39

mu/l

1.07

456

1091

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1032

3209

1.64

42.86

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1471

4973

1.51

42.83

1.2

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

214

346

3.14

42.67

2.1

73.25

63.25

ug/l

0.58

207

336

(3003740) Influenza virus B Ag [Presence] in Specimen

1134

3617

1.60

42.57

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

414

952

2.21

42.35

1.2

16.02

12.55

u/ml

0.16

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

689

1914

1.83

42.33

2.4

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

199

309

3.27

42.19

3.4

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

199

309

3.27

42.19

3.4

2.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

931

2830

1.68

42.13

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

9.86

41.52

1.2

1.4

5.68

6.14

mmol/l

0.16

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

562

1469

1.95

41.39

1.1

247.50

265.72

mg/l

0.84

495

1294

(3006653) Thiamine [Moles/volume] in Blood

317

653

2.47

41.22

1.4

1.2

135.87

135.96

nmol/l

0.01

317

653

(3012441) Differential panel - Pleural fluid

495

1237

2.04

41.21

1.5

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

579

1532

1.92

41.18

1.2

1.1

37.92

44.92

mg/l

2.20

489

1276

(3006245) CD3-CD19+ cells/100 cells in Blood

310

637

2.47

40.53

2.6

2.3

9.92

10.70

0.48

291

598

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

462

1133

2.07

40.40

1.3

1.51

2.57

u/ml

1.34

253

637

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1642

5746

1.46

40.40

1.1

5.68

5.24

u/ml

0.12

188

924

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

409

956

2.18

40.29

1.9

1.6

4.22

3.62

mg/l

1.33

390

901

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

303

620

2.48

39.96

2.5

2.1

29.52

28.87

0.31

287

589

(3045788) Cell count panel - Pleural fluid

452

1104

2.08

39.95

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

620

1697

1.86

39.91

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

160

222

3.66

39.74

1.2

39.57

39.47

g/l

0.02

122

(3017569) Oxygen content in Arterial blood

247

455

2.76

39.73

2.5

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

258

487

2.69

39.72

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

258

488

2.69

39.57

1.4

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

658

1843

1.82

39.43

1.2

1.1

—

(3045716) Anion gap in Serum or Plasma

259

492

2.67

39.41

2.4

2.5

9.93

9.89

mmol/l

0.05

252

476

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

350

772

2.31

39.41

1.3

1.2

67.81

68.73

0.06

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

631

1745

1.84

39.35

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1520

5267

1.48

39.30

3.6

2389.89

2878.64

u/ml

0.09

1289

4551

(3019832) Treponema pallidum Ab [Presence] in Serum

7149

30797

1.20

38.63

1.8

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

501

1294

1.97

38.20

1.5

1.4

77290.21

43127.82

e6/l

1.06

293

774

(3029634) Reagin Ab [Titer] in Serum by VDRL

991

3150

1.60

37.77

2.0

2.3

4.06

8.19

titre

1.16

113

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

619

1725

1.83

37.72

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

582

1594

1.86

37.42

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

462

1169

2.01

37.27

12.2

10.9

0.59

0.61

mmol/l

0.70

431

1069

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

366

848

2.19

36.87

1.8

1.5

1732887.39

1495650.36

iu/ml

0.16

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

562

1530

1.87

36.81

2.0

2.3

19.85

21.45

nmol/l

2.95

529

1472

(3051387) C reactive protein [Mass/volume] in Capillary blood

1118

3684

1.55

36.60

3.8

2.4

27.07

27.16

mg/l

0.03

726

2251

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

533

1437

1.89

35.96

1.2

63.48

68.29

u/l

0.48

475

1307

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

311

680

2.32

35.76

1.6

3.94

7.29

nmol/l

0.45

254

569

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

533

1442

1.88

35.60

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

188

316

3.02

35.37

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

371

882

2.14

35.16

1.5

1.4

12.89

12.31

u/l

0.75

355

858

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

462

1200

1.96

34.73

3.4

4.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

297

647

2.33

34.45

1.7

2.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

161

250

3.27

34.24

1.3

35.09

43.12

1.54

110

177

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

296

646

2.33

34.20

1.7

2.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

668

1966

1.73

34.04

1.2

1.1

96.16

95.24

0.35

625

1856

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

337

782

2.19

33.88

1.1

1.2

17.08

13.73

u/ml

0.12

(3000093) Morphology [Interpretation] in Blood Narrative

510

1384

1.87

33.78

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

324

742

2.22

33.60

1.0

1.1

96.57

95.32

0.28

267

592

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1091

3646

1.53

33.56

1.5

1.4

131.11

101.31

pmol/l

0.86

1058

3553

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

571

1615

1.80

33.26

3.2

3.1

5.46

8.98

nmol/l

0.49

553

1560

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

278

599

2.36

33.05

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

281

609

2.34

32.99

2.2

2.0

8.80

9.68

mg/l

1.61

239

491

(3012565) Volume of 24 hour Urine

298

665

2.28

32.80

2.3

2.1

1994.20

2050.05

0.32

271

602

(3017704) Immunofixation for Urine

259

542

2.43

32.75

1.7

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

298

666

2.27

32.70

1.2

1.1

3.64

4.28

iu/ml

0.38

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

261

549

2.42

32.65

1.2

109.86

104.91

0.89

231

502

(3035880) pH of Pleural fluid

270

578

2.37

32.55

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

450

1191

1.92

32.12

1.6

1.7

—

(3023410) Appearance of Cerebral spinal fluid

608

1775

1.74

31.89

1.7

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

516

1436

1.83

31.67

2.3

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

338

811

2.12

31.38

1.3

14.81

13.63

u/l

0.33

312

754

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

372

927

2.04

31.36

2.8

42.68

38.91

2.88

233

413

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

219

431

2.58

31.32

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

477

1302

1.86

31.10

3.3

2.8

72.32

51.78

mg/l

0.54

364

917

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

255

545

2.38

30.88

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

229

467

2.49

30.56

1.9

1.6

133.28

153.98

au/ml

0.18

(21494815) CD4 cells/100 lymphocytes in Specimen

530

1509

1.79

30.27

2.6

2.2

39.23

37.86

1.17

519

1487

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

241

507

2.41

30.19

3.8

4.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

253

545

2.36

30.15

1.1

93.38

89.85

0.80

120

264

(3039162) Centromere protein B Ab [Units/volume] in Serum

673

2055

1.67

30.10

1.3

1.2

66.39

52.43

u/ml

0.56

116

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

247

529

2.37

29.81

1.1

95.64

87.37

2.13

121

259

(3045142) Bone marrow Pathology biopsy report

533

1528

1.77

29.77

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1023

3463

1.51

29.70

2.1

2.3

6.72

6.22

umol/l

0.25

738

2561

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4241

25727

0.82

29.40

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

253

552

2.33

29.34

5.2

4.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

304

721

2.14

29.09

1.8

1.9

1.98

1.88

umol/l

1.20

286

674

(44813793) Dust mix specific IgE antibody measurement

459

1267

1.84

28.96

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

412

1099

1.91

28.81

2.8

1.9

—

(3010503) CD19 cells [#/volume] in Blood

352

888

2.01

28.77

2.5

2.7

0.37

e9/l

0.01

342

870

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

226

472

2.43

28.77

2.7

2.8

28.41

28.11

umol/l

0.12

155

361

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

356

902

2.01

28.76

2.7

3.4

107.64

128.51

nmol/l

0.57

347

892

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

141

226

3.17

28.69

1.4

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7844

34850

1.16

28.64

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

230

486

2.40

28.58

2.7

2.1

270.60

677.59

e6/l

0.38

117

257

(3028433) Virus identified in Specimen by Culture

219

452

2.46

28.57

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

236

505

2.37

28.56

2.4

2.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

471

1318

1.82

28.48

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

222

462

2.44

28.47

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

335

833

2.04

28.46

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

471

1319

1.82

28.41

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

258

2.99

28.27

5.5

6.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

471

1322

1.81

28.21

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

227

481

2.40

28.06

1.6

1.7

1120.86

16572.59

u/ml

0.92

(3008037) Lactate [Moles/volume] in Venous blood

941

3170

1.51

27.98

3.5

2.5

1.58

mmol/l

0.05

917

3108

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

348

884

2.00

27.94

1.1

5.35

5.31

nmol/l

0.01

179

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

295

703

2.13

27.93

2.4

2.5

52.02

52.80

umol/l

0.15

256

625

(3051611) Lipemic interference index of Serum or Plasma

520

1510

1.75

27.86

3.6

3.0

—

(3047189) Immunofixation for 24 hour Urine

226

480

2.39

27.80

1.8

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

922

3098

1.52

27.75

1.1

9.69

12.89

au/ml

0.78

248

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

348

887

1.99

27.69

1.1

1460.48

1457.36

miu/ml

0.02

348

887

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

314

770

2.07

27.67

1.7

1.6

2.52

u/field

0.00

241

549

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

314

771

2.07

27.58

1.4

1.6

28.77

21.89

u/ml

1.20

167

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

445

2.44

27.51

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

465

1312

1.80

27.41

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

815

2672

1.55

27.40

1.7

2.0

3637.50

4105.92

titre

0.09

142

(40759836) Histone Ab [Presence] in Serum by Immunoblot

463

1310

1.80

27.05

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

463

1312

1.79

26.92

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1030

3565

1.47

26.89

2.8

1.8

0.89

0.78

nmol/l

4.79

858

3039

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

187

368

2.58

26.83

1.5

1.3

63.44

59.86

0.60

157

293

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

386

1038

1.89

26.41

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

256

589

2.21

26.40

2.0

1.9

152.50

163.66

0.92

237

555

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

414

1140

1.85

26.37

2.0

1.8

2.17

2.03

u/field

0.17

206

478

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

436

1225

1.81

26.08

2.8

2.6

715.48

655.46

e6/l

1.18

424

1199

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

527

1569

1.71

25.93

2.0

1.9

19.54

28.80

ug/l

4.86

519

1540

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

252

583

2.20

25.67

3.6

3.3

—

(3051651) Icteric interference index of Serum or Plasma

345

903

1.94

25.56

4.0

3.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

398

1095

1.85

25.44

2.0

2.6

100.25

92.72

4.02

361

1038

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

834

2803

1.52

25.12

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

442

1265

1.78

24.93

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2845

17686

0.80

24.91

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

705

2287

1.57

24.86

1.2

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

131

220

3.02

24.86

1.2

1.1

64.16

67.82

mg/l

0.03

152

(3001893) Eosinophils/100 leukocytes in Pleural fluid

164

315

2.64

24.69

1.5

1.3

2.70

2.64

0.03

143

261

(3047007) Chlamydophila sp Ab [Presence] in Serum

839

2839

1.50

24.49

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

236

542

2.21

24.49

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

914

3153

1.48

24.31

1.1

10930.64

929.67

iu/ml

0.51

227

713

(3020717) Zinc [Moles/volume] in Serum or Plasma

309

792

1.98

24.30

1.6

1.4

20.71

29.12

umol/l

5.02

295

761

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1323

4888

1.38

24.19

1.1

2.29

2.54

u/ml

0.32

688

2488

(3019420) Tryptase [Mass/volume] in Serum or Plasma

343

914

1.91

24.17

1.5

7.75

6.86

ug/l

0.58

301

826

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

747

2473

1.54

24.12

1.1

1.51

1.48

g/l

1.26

690

2234

(3027923) C peptide [Moles/volume] in Serum or Plasma

306

784

1.98

24.09

1.7

1.6

1.30

1.17

nmol/l

1.08

238

620

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

655

2105

1.58

24.05

3.8

3.2

30.68

39.86

u/ml

1.13

637

2023

(4146454) Self-monitoring of blood glucose

473

1403

1.71

23.64

2.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

366

1005

1.85

23.59

1.6

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

121

200

3.07

23.57

1.9

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

744

2475

1.53

23.52

2.4

2.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

207

457

2.30

23.52

1.2

19.00

17.91

0.07

(3022493) Free Hemoglobin [Mass/volume] in Plasma

262

643

2.07

23.15

5.2

5.4

1682.43

1930.92

mg/l

0.07

190

446

(3020491) Glucose [Moles/volume] in Blood

435

1268

1.74

23.11

1.8

1.5

6.68

6.40

mmol/l

0.99

324

966

(40762814) Titanium [Mass/volume] in Blood

102

4.03

22.95

2.3

2.4

4.11

4.26

ug/l

0.05

(3037692) Legionella sp identified in Specimen by Organism specific culture

193

419

2.34

22.77

1.5

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

217

497

2.22

22.71

1.3

1.2

0.24

0.55

g/l

0.55

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

380

1070

1.80

22.66

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

298

779

1.94

22.24

24.4

27.3

124.70

114.81

ug/l

0.76

240

667

(3034988) Calcium [Moles/volume] in Capillary blood

127

225

2.86

22.13

3.4

2.0

1.19

1.18

mmol/l

0.03

122

216

(3016228) CD19 cells/100 cells in Blood

239

578

2.10

21.95

2.2

2.0

9.35

8.64

0.31

233

566

(40762365) Oxygen content in Arterial blood by calculation

106

169

3.18

21.87

3.4

2.2

14.65

15.15

ml/dl

0.79

100

150

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

471

1427

1.68

21.85

1.4

1.5

—

(3006270) Folate [Moles/volume] in Blood

433

1285

1.71

21.66

1.2

1.1

372.00

389.73

nmol/l

0.80

378

1111

(3038515) Glucose [Moles/volume] in Venous blood

865

3026

1.46

21.50

3.7

2.5

7.58

7.54

mmol/l

0.14

843

2979

(3002079) Sodium [Moles/time] in 24 hour Urine

279

722

1.96

21.44

1.3

166.10

161.55

mmol/24h

0.34

279

722

(3000919) Neutrophils/100 leukocytes in Pleural fluid

140

267

2.66

21.43

1.6

1.3

25.30

22.32

0.51

130

245

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

260

656

2.01

21.41

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

413

1215

1.73

21.31

1.3

1.2

5.66

5.73

umol/l

0.12

383

1141

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

246

609

2.05

21.30

1.3

1.2

0.30

0.29

g/l

0.39

189

478

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

524

1644

1.62

21.29

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

315

853

1.88

21.24

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

233

566

2.09

21.19

2.2

2.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

443

1332

1.69

21.16

1.1

48.60

69.32

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

1203

4475

1.37

21.15

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

409

1204

1.73

21.06

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

144

282

2.59

20.99

6.9

6.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

132

247

2.71

20.93

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1015

3681

1.40

20.76

1.5

0.42

0.41

nmol/l

0.10

804

3023

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

221

530

2.12

20.76

1.9

2.3

—

(3002619) Bacteria identified in Specimen by Culture

134

254

2.68

20.76

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

310

843

1.87

20.66

1.2

95.16

89.59

u/l

0.32

268

749

(40757373) Influenza virus identified in Isolate

125

229

2.77

20.59

1.6

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

314

860

1.85

20.48

1.6

5.99

7.33

u/l

0.87

249

709

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

363

1041

1.77

20.45

1.1

1.01

1.08

u/l

1.08

161

457

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1192

4453

1.36

20.43

1.9

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.16

20.39

1.6

1.7

44.76

43.39

umol/l

0.10

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

302

820

1.87

20.23

1.5

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

216

521

2.10

20.03

1.9

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

216

521

2.10

20.03

1.9

2.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

227

559

2.06

19.97

1.3

1.2

109.43

110.73

0.31

200

504

(3003888) Timothy IgE Ab [Units/volume] in Serum

1185

4444

1.36

19.83

1.1

6.65

6.55

u/ml

0.06

645

2387

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

225

554

2.06

19.81

1.5

1.4

14.72

14.62

pmol/l

0.05

191

465

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

187

427

2.22

19.79

2.1

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

444

1364

1.65

19.63

1.9

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

199

469

2.15

19.55

11.5

8.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

269

711

1.92

19.53

1.3

446.25

346.51

titre

0.16

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

256

665

1.95

19.53

1.1

1.2

90.11

79.91

u/l

0.82

232

607

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

224

554

2.05

19.50

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

255

664

1.95

19.32

1.2

28.50

20.43

u/l

1.24

232

607

(21494434) Karyotype in Bone marrow

393

1176

1.70

19.16

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

103

3.69

19.14

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

938

3409

1.40

19.00

1.6

1.5

—

(3007463) Buprenorphine [Presence] in Urine

4.30

18.71

5.5

5.4

—

(3003129) Base excess in Capillary blood by calculation

130

258

2.56

18.54

1.8

1.5

0.42

0.46

mmol/l

0.03

122

240

(3033705) Calcium.ionized [Moles/volume] in Venous blood

524

1702

1.57

18.54

2.7

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1125

4231

1.35

18.52

1.1

1.18

1.19

u/ml

0.01

492

1881

(40761539) Cells [Type] in Urine sediment by Light microscopy

151

323

2.37

18.50

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

127

250

2.58

18.40

7.1

6.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

593

1984

1.52

18.40

1.4

8.47

7.76

mmol/l

3.47

574

1925

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

295

822

1.82

18.31

1.2

25.15

20.87

u/l

0.49

252

725

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

111

204

2.76

18.25

2.2

2.3

7.49

7.44

mmol/l

0.04

107

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

257

686

1.90

18.18

1.9

27.24

28.91

umol/l

1.80

248

659

(3023383) Lactate [Moles/volume] in Pleural fluid

145

308

2.39

18.05

1.3

3.69

3.58

mmol/l

0.13

131

288

(3021162) Amylase [Enzymatic activity/volume] in Specimen

172

2.92

17.92

3.7

2.6

3072.63

670.35

u/l

1.34

153

(40768793) Breast Pathology biopsy report

908

3323

1.39

17.70

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

338

992

1.73

17.69

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

263

716

1.87

17.56

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

460

1468

1.59

17.56

2.2

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

131

3.21

17.49

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

453

1442

1.60

17.48

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

233

610

1.94

17.45

2.1

2.3

1.07

0.95

ug/l

0.36

212

569

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

157

352

2.26

17.40

1.2

1.1

75.62

74.61

0.06

(1761482) Bacteria [#/volume] in Urine by Culture

1063

4006

1.35

17.30

4.5

3.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

134

282

2.41

17.04

1.6

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

255

695

1.86

16.99

1.3

73.48

91.03

titre

0.25

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

866

3167

1.39

16.98

1.3

—

(40768795) Lymph node Pathology biopsy report

470

1521

1.57

16.94

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

272

758

1.82

16.92

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

101

184

2.78

16.90

7.0

6.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

420

1325

1.61

16.83

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

422

1333

1.61

16.82

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.59

16.79

2.1

2.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

155

352

2.23

16.70

1.2

1.1

82.80

86.94

0.29

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

106

200

2.69

16.67

7.3

5.7

69.77

73.77

0.68

159

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

125

258

2.46

16.56

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

194

485

2.03

16.52

1.6

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

280

798

1.78

16.24

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

182

448

2.06

16.15

4.0

3.2

53.60

50.33

1.00

177

432

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

247

678

1.85

16.14

1.1

—

(21494755) Public health laboratory ask at order entry panel

5152

29405

0.88

16.11

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

181

2.75

16.03

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

154

357

2.19

15.85

1.1

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

159

375

2.15

15.71

1.5

1.3

105.14

103.67

0.18

151

350

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

267

758

1.79

15.70

2.1

2.5

49.59

343.10

ug/l

1.30

256

714

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

130

3.08

15.67

1.5

1.6

1.63

1.81

mg/l

0.12

(43055442) Apixaban [Mass/volume] in Serum or Plasma

102

3.38

15.48

1.4

1.5

129.45

114.66

ug/l

0.37

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

239

661

1.84

15.29

1.1

256.18

530.10

ng/l

0.68

147

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

155

366

2.15

15.29

1.4

1.2

140.46

126.29

nmol/l

0.28

123

272

(40765096) Chromosome analysis panel by Banding

155

367

2.14

15.19

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

154

364

2.15

15.16

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

4.69

3.46

mg/l

0.64

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

1.40

1.74

mg/l

0.22

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

0.91

1.80

mg/l

0.96

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

2.45

2.28

mg/l

0.08

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

1.59

1.89

mg/l

0.19

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

1.79

1.72

mg/l

0.05

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

2.19

2.10

mg/l

0.06

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

1.08

0.71

mg/l

0.54

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

129

3.03

14.87

1.5

1.6

2.09

2.20

mg/l

0.05

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1093

4233

1.31

14.85

1.1

2.24

2.42

u/ml

0.20

570

2126

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

139

318

2.22

14.79

1.5

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

131

293

2.27

14.68

1.2

1.3

102.82

312.38

ug/l

1.61

160

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

162

397

2.07

14.60

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

128

3.01

14.57

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

105

213

2.50

14.47

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2165

9124

1.21

14.32

2.0

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

818

3053

1.36

14.26

1.3

1.4

6.96

6.90

mmol/l

0.27

739

2703

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

276

817

1.72

14.15

1.0

744.91

748.78

ng/l

0.04

185

614

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

463

1559

1.51

14.09

1.2

—

(3034426) Prothrombin time (PT)

227

635

1.81

14.06

1.2

—

(3011048) Pyruvate [Moles/volume] in Blood

3.48

14.02

1.3

1.5

87.60

73.91

umol/l

1.30

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

274

812

1.71

14.00

1.0

276.83

329.55

ng/l

2.62

189

629

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

276

820

1.71

13.98

1.0

38.30

40.90

ng/l

0.52

184

630

(3038177) Helicobacter pylori Ab [Presence] in Serum

906

3450

1.34

13.88

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

131

301

2.21

13.84

1.1

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

105

218

2.44

13.83

1.8

37.07

33.80

pmol/l

0.15

179

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

158

392

2.04

13.82

1.1

—

(3024932) HLA-DR beta [Type]

209

575

1.84

13.66

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

142

2.82

13.63

1.6

1.3

291.70

156.88

titre

—

(3036071) Salmonella sp Ab [Titer] in Serum

214

595

1.83

13.54

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

238

684

1.77

13.53

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

159

399

2.02

13.51

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

238

685

1.76

13.47

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

354

1135

1.58

13.40

1.1

8.28

8.05

iu/ml

0.05

335

(3024471) HLA-A [Type]

211

588

1.82

13.26

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

107

229

2.37

13.26

1.1

1.0

74.57

81.79

ug/l

0.98

188

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

158

399

2.01

13.22

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

445

1509

1.50

13.14

1.0

1.1

291.63

285.10

mg/l

0.76

409

1358

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

146

359

2.06

13.10

1.3

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

178

2.56

13.08

1.7

1.62

1.66

mg/l

0.09

150

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

146

2.74

13.01

2.0

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

405

1354

1.52

12.80

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

208

2.41

12.77

3.6

3.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

291

901

1.64

12.71

5.4

7.9

835.98

4317.04

u/ml

0.73

252

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

200

2.43

12.60

1.5

1.4

236715.62

243982.37

nmol/l

0.01

166

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

106

232

2.32

12.54

1.5

0.42

0.45

ug/l

0.16

151

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

126

298

2.14

12.48

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

252

756

1.69

12.39

2.9

2.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

116

266

2.21

12.37

1.1

1.29

5.24

umol/24h

0.40

155

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

227

663

1.74

12.28

2.5

3.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

108

241

2.27

12.26

1.4

88.60

488.83

ng/l

0.56

148

(3004775) Volume in Urine collected for unspecified duration

370

1225

1.53

12.25

2.0

2.4

684.24

638.68

1.09

251

848

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

100

216

2.35

12.19

3.6

3.0

21.59

23.44

mg/l

0.71

204

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

407

1382

1.50

12.00

1.4

12.81

11.31

umol/l

3.66

382

1309

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

168

2.54

11.99

1.6

1.4

6.61

15.57

2.97

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.10

11.70

1.1

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

211

2.33

11.67

4.2

5.0

47.66

39.75

ug/min

0.51

158

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

476

1678

1.44

11.64

5.1

4.5

69.95

99.43

u/ml

0.79

150

555

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

278

872

1.62

11.59

1.1

7.03

11.63

u/ml

1.14

165

(3012898) Urea [Moles/volume] in Urine

147

2.62

11.57

1.4

1.8

163.10

173.23

mmol/l

0.24

135

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

208

603

1.75

11.57

1.1

—

(4281824) Cell count and differential, peritoneal fluid

460

1614

1.45

11.53

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

134

337

2.02

11.41

1.2

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

113

266

2.15

11.37

2.2

2.8

45.86

41.11

mg/l

0.08

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

435

1517

1.46

11.27

13.3

13.9

845.57

1814.46

nmol/l

0.72

415

1477

(3016750) Collection duration of Urine

279

883

1.60

11.24

2.0

2.2

498.62

502.32

min

0.24

208

675

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

215

2.29

11.22

1.1

—

(3015183) Erythrocyte sedimentation rate

331

1092

1.54

11.18

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

3.10

11.13

1.2

1.1

11.01

8.92

mg/l

0.62

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

237

722

1.67

11.08

2.1

94.06

103.54

ug/min

0.08

173

(3009871) Measles virus Ab [Titer] in Serum

214

634

1.71

11.07

1.7

1.6

—

(3022689) Creatine [Moles/volume] in Urine

156

420

1.88

11.00

1.6

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

113

2.83

10.99

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

176

493

1.81

10.99

2.8

3.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

912

3597

1.29

10.97

1.1

4.17

4.53

u/ml

0.17

448

1773

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

4.01

10.92

1.1

1.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

147

390

1.91

10.82

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

209

2.28

10.82

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

147

391

1.91

10.75

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

145

384

1.92

10.74

1.7

2.0

53.56

45.46

u/l

0.17

134

339

(3041918) Cholesterol [Moles/volume] in Pleural fluid

189

2.33

10.55

1.1

1.2

1.59

1.88

mmol/l

0.99

107

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

146

391

1.89

10.48

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

690

2637

1.33

10.45

3.0

3.1

76.67

718.74

u/ml

1.59

679

2607

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

199

588

1.72

10.43

1.1

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

163

2.43

10.27

1.6

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

121

2.68

10.21

2.3

1.9

1.26

1.34

umol/l

0.86

104

(3001186) Copper [Moles/volume] in Serum or Plasma

156

433

1.83

10.07

1.5

1.2

16.85

16.39

umol/l

0.54

142

377

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

122

2.66

10.07

1.2

1.3

604.86

62.57

u/l

0.65

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

111

2.74

9.96

1.5

1.3

13.04

11.91

pmol/l

0.14

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.18

9.92

1.0

8.53

20.19

iu/ml

0.95

(3011544) Albumin [Mass/volume] in Pleural fluid

2.96

9.85

1.1

17.59

16.42

g/l

0.39

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

346

1.92

9.82

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

304

1017

1.52

9.72

7.1

6.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

846

3360

1.28

9.70

1.1

5.76

5.50

u/ml

0.10

357

1461

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

116

295

1.99

9.67

1.1

1.3

250.24

397.38

pmol/l

1.59

216

(37021550) Renin [Units/volume] in Plasma --upright

109

272

2.03

9.56

1.3

1.4

135.36

91.77

mu/l

0.27

213

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

198

2.23

9.56

1.1

—

(3001556) Androgen free Index in Serum or Plasma

111

280

2.01

9.47

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

173

2.32

9.46

2.4

3.2

41.82

44.09

umol/l

0.33

145

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

131

351

1.89

9.44

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

444

1609

1.40

9.44

18.3

19.5

3608.82

2772.35

nmol/l

0.14

426

1553

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

121

2.60

9.37

1.2

1.1

20.23

22.12

u/l

0.20

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.19

9.35

12.5

9.2

167.31

345.91

e6/l

0.50

(3036603) Volume of Urine

313

1066

1.49

9.23

1.6

2096.82

1986.35

1.11

304

1049

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

185

2.25

9.21

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

215

673

1.62

9.16

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

406

1460

1.41

9.04

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

433

1576

1.40

9.00

1.3

157.14

177.06

titre

0.07

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

197

2.19

8.98

1.6

1.5

—

(3014891) Appearance of Pleural fluid

165

2.30

8.92

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

215

679

1.61

8.86

1.4

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

328

1138

1.46

8.85

1.4

5.51

5.44

mmol/l

0.42

307

1084

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

433

1581

1.39

8.85

1.3

209.60

207.50

titre

0.02

268

(3042010) Triglyceride [Moles/volume] in Pleural fluid

163

2.30

8.78

1.2

1.76

1.88

mmol/l

0.04

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

102

260

1.99

8.51

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

342

1207

1.44

8.47

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

116

311

1.89

8.41

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

116

311

1.89

8.41

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

116

311

1.89

8.41

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

116

311

1.89

8.41

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

237

2.03

8.40

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1237

7487

0.83

8.35

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.80

8.33

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

1235

7469

0.83

8.27

1.4

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

101

260

1.97

8.22

1.8

1.5

2.10

2.09

ug/l

0.01

150

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

734

2928

1.27

8.21

1.1

1.0

0.71

0.43

u/ml

0.50

217

719

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

162

2.25

8.19

3.3

3.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

137

2.37

8.11

1.3

28.38

26.71

0.12

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.94

7.95

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

191

2.12

7.93

1.2

57.65

55.42

0.12

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

108

289

1.89

7.90

2.3

2.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1273

7640

0.84

7.84

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.87

7.81

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.93

7.70

1.8

2.6

—

(3024869) Neuronal Ab [Presence] in Serum

221

2.02

7.69

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

187

2.11

7.67

1.2

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

218

2.02

7.65

1.8

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

171

532

1.63

7.56

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

169

2.16

7.46

2.5

2.0

0.47

0.62

u/field

0.63

169

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

808

3300

1.24

7.45

1.1

2.73

2.96

u/ml

0.19

379

1786

(3001729) Color of Synovial fluid

2.65

7.44

1.4

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

130

377

1.75

7.42

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

163

2.18

7.40

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2871

13023

1.12

7.38

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

164

2.16

7.30

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

247

1.93

7.28

1.5

1.6

—

(3048879) Bone marrow aspiration report

117

331

1.79

7.26

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.88

7.25

1.2

1.0

—

mmol/l

—

(3013466) aPTT in Blood by Coagulation assay

2.62

7.16

1.0

1.2

37.18

36.43

0.25

(3020650) Glucose [Presence] in Urine

155

478

1.64

7.12

1.5

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

102

278

1.86

7.12

2.2

2.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.65

7.02

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

16717

81540

1.06

6.97

2.7

2.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

138

2.24

6.92

4.1

4.8

2.31

2.53

mg/l

0.34

112

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.92

6.81

1.3

1.0

3566.75

2865.52

ng/l

0.26

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

105

2.41

6.67

3.2

5.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

197

655

1.53

6.66

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

218

1603

0.69

6.64

1.6

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.71

6.48

3.3

3.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.63

6.46

1.3

1.2

120.57

129.02

ug/l

0.10

(3002621) Streptococcal DNAse B [Units/volume] in Serum

143

2.16

6.40

1.1

—

(3017509) Phencyclidine [Presence] in Urine

107

307

1.77

6.40

2.2

1.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

248

1.86

6.40

1.1

1.0

0.02

0.23

u/ml

0.93

155

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

2.10

6.35

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

127

2.24

6.35

1.3

1.5

76.24

71.05

0.59

102

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.60

6.32

1.4

1.2

22.30

21.71

mmol/l

0.27

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

272

1.81

6.26

1.3

1.4

20.39

22.26

0.26

218

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.82

6.23

2.6

1.9

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

255

907

1.43

6.21

1.4

438.33

782.89

mu/l

1.80

247

859

(3027035) Albumin [Mass/time] in 24 hour Urine

135

2.18

6.21

1.3

681.69

253.13

mg/24h

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

194

654

1.50

6.19

1.1

7.47

22.42

u/ml

0.49

387

(3020618) Glucose [Moles/volume] in Synovial fluid

4.22

6.19

1.1

4.93

4.97

mmol/l

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.60

6.18

1.5

1.7

0.73

0.81

0.06

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

302

1108

1.38

6.17

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

156

2.08

6.13

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.82

6.09

1.1

24.23

24.29

u/ml

—

(3036048) Francisella tularensis Ab [Titer] in Serum

135

420

1.63

6.07

1.1

1.2

582.86

527.69

titre

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.68

6.05

1.2

1.4

15.85

11.13

0.38

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

253

1.82

6.05

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

359

1359

1.34

6.04

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

217

1.89

6.02

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

127

2.20

6.01

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

259

930

1.41

6.00

1.4

72.21

73.37

0.68

251

882

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

221

1.88

5.99

1.1

1.2

36.15

43.02

mg/l

0.70

186

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.83

5.95

1.4

1.3

1.35

1.53

mg/l

0.65

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.73

5.92

1.2

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

204

1.91

5.92

2.4

2.9

72.08

67.75

pmol/l

0.08

184

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.29

5.91

1.0

1.1

0.15

0.01

u/ml

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

102

2.34

5.90

1.1

17.43

7.96

u/l

0.96

102

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.42

5.68

1.5

1.2

25.32

15.91

pmol/l

0.63

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.61

5.63

4.7

4.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1633

7285

1.14

5.58

1.8

1.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

102

2.29

5.53

1.3

—

13.40

—

(1617658) Protocol used for examination of sentinel lymph nodes

276

1019

1.37

5.49

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

109

2.23

5.48

1.5

1.2

324.98

317.88

umol/24h

0.10

109

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

2.02

5.48

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

110

334

1.67

5.47

1.1

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

258

1.77

5.47

1.2

1.4

35.50

205.15

titre

1.15

(3020874) Milk IgE Ab [Units/volume] in Serum

390

1518

1.30

5.46

1.1

2.46

3.69

u/ml

0.33

138

472

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.39

5.42

1.2

1.3

30.46

33.15

0.13

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

204

1.86

5.38

1.1

6.12

3.20

pmol/l

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.47

5.37

1.4

1.1

3454.55

580.03

u/l

0.68

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

197

1.88

5.36

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.71

5.21

1.2

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

382

1493

1.30

5.21

1.1

1.0

2.90

1.98

u/ml

0.28

105

360

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.44

5.11

7.4

4.4

—

(3035933) Granulocytes/100 leukocytes in Blood

170

583

1.48

5.09

1.9

1.8

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.50

5.08

1.4

1.1

1.07

1.00

u/field

0.38

(3013247) Albumin in CSF/Albumin in Serum or Plasma

140

461

1.54

5.06

1.0

1.1

6.52

6.62

mg/g

0.05

135

440

(3026692) Albumin [Mass/volume] in Peritoneal fluid

124

397

1.58

5.06

1.5

1.4

14.27

12.18

g/l

1.58

293

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

231

1.78

5.04

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

288

1.69

5.03

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

140

462

1.54

5.02

1.4

1.6

9.01

8.95

ug/l

0.05

140

462

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.47

4.96

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.47

4.96

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.47

4.96

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.47

4.96

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.47

4.96

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.47

4.96

2.0

1.9

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.72

4.93

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

207

1.81

4.91

2.3

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

194

690

1.43

4.84

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

201

1.82

4.81

1.1

1.0

—

(40758292) HTLV I+II Ab panel - Serum

104

324

1.63

4.76

1.3

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.22

4.68

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

163

1.90

4.66

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.74

4.65

1.0

1.1

0.17

0.03

u/ml

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.53

4.65

1.2

1.3

0.65

1.51

0.66

(3041672) Baker's yeast Ab [Presence] in Serum

104

2.14

4.64

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

179

1.84

4.55

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

105

2.12

4.54

1.0

1.12

0.44

u/ml

0.34

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

112

2.08

4.52

1.1

19.21

18.96

0.01

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.13

4.49

1.5

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

443

1.51

4.44

1.1

—

(3019174) dRVVT (LA screen)

152

1.90

4.40

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

204

1.76

4.37

2.0

2.4

1.31

1.40

mmol/l

0.07

151

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

936

4095

1.16

4.32

1.4

1.3

4.26

3.84

ug/l

0.37

850

3794

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

225

1.71

4.24

1.0

0.25

0.62

u/ml

0.47

120

(3007700) Barley IgE Ab [Units/volume] in Serum

2.19

4.23

1.0

0.88

0.61

u/ml

0.17

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

117

388

1.53

4.18

1.4

1.6

0.21

0.25

nmol/l

0.50

296

(3027231) Wheat IgE Ab [Units/volume] in Serum

129

437

1.50

4.18

1.1

1.0

1.63

2.98

u/ml

0.39

105

391

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

230

1.70

4.17

1.0

4.57

3.66

u/ml

0.07

117

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

152

1.87

4.13

1.4

1.1

—

(40768441) Liver Pathology biopsy report

359

1439

1.27

4.12

1.3

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

133

455

1.48

4.12

2.8

2.2

107.12

116.89

ng/l

0.24

275

(3028468) Fragments [Presence] in Blood by Light microscopy

9.12

4.09

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.53

4.08

1.4

1.3

502.27

529.72

nmol/l

0.07

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

153

1.86

4.06

1.1

2.12

3.90

umol/24h

0.34

153

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

240

1.67

4.04

1.0

0.14

0.20

u/ml

0.26

152

(4212803) Bone marrow aspirate examination

118

1.98

3.99

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

101

2.06

3.96

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

170

1.79

3.90

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

130

1.91

3.89

1.0

0.24

0.40

u/ml

0.53

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.38

3.83

1.9

2.8

2.89

2.75

mu/l

0.03

(40768800) Prostate Pathology biopsy report

790

3447

1.16

3.83

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

149

1.84

3.82

3.4

3.0

1.54

1.27

mg/l

0.22

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

106

2.01

3.82

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

284

1123

1.28

3.69

1.2

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

235

1.64

3.67

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

112

1.95

3.61

1.2

1.1

1.35

3.52

u/ml

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.08

3.58

1.0

1.4

115.83

32.23

e6/l

0.63

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

2.59

3.51

1.0

19.78

9.72

u/ml

0.69

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

132

1.84

3.47

1.0

17.38

24.13

u/ml

0.44

105

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

195

739

1.34

3.46

1.1

1.0

12.62

13.85

u/ml

0.24

110

434

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

763

4445

0.87

3.46

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

213

819

1.32

3.43

2.6

2.3

159.47

154.63

nmol/l

0.19

178

712

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

118

1.89

3.43

1.1

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.15

3.38

1.5

2.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

104

354

1.49

3.38

1.1

1.2

0.31

2.73

u/ml

1.23

104

348

(40763791) Oxygen content in Venous blood by calculation

2.75

3.37

6.3

4.4

12.29

13.05

ml/dl

0.27

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.60

3.36

5.0

5.6

0.94

1.05

mg/l

0.23

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.99

3.35

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.17

3.35

2.8

3.9

—

(3024316) Viscosity of Plasma

2.17

3.35

1.6

1.58

1.71

mpas

0.28

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

123

1.85

3.32

1.7

2.5

63.03

52.79

0.94

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.97

3.31

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.97

3.26

1.3

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.07

3.26

1.5

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

334

1369

1.24

3.26

1.0

0.73

0.75

u/ml

0.02

335

(3046861) Legionella sp Ag [Presence] in Urine

2.24

3.25

1.0

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.95

3.23

1.1

1.44

3.69

u/l

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.60

3.22

1.6

3.3

1422.00

1752.40

umol/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

209

1.62

3.18

1.1

1.0

0.71

0.52

u/ml

0.17

114

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

159

1.72

3.17

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.11

3.15

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.11

3.15

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1573

7260

1.10

3.14

1.5

1.4

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.38

3.13

1.2

1.1

1.20

1.32

u/field

0.23

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

195

1.64

3.10

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

213

833

1.30

3.08

1.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

169

1.68

3.03

2.9

2.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

109

1.86

3.01

1.1

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

143

1.74

2.98

1.1

37.66

31.01

u/ml

0.21

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

143

1.74

2.98

1.1

29.15

28.19

u/ml

0.04

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

128

1.78

2.98

1.0

0.67

2.50

u/ml

0.83

100

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.92

2.98

1.6

2.6

14.50

18.37

0.27

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.42

2.97

1.0

0.04

0.06

u/ml

0.18

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.92

2.95

1.0

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

116

416

1.41

2.94

1.1

3.46

8.54

u/ml

0.81

302

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.79

2.93

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.29

2.90

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

553

2406

1.17

2.89

1.5

1.6

7.99

7.44

mmol/l

5.96

535

2304

(3050794) Legionella sp Ab [Presence] in Serum

142

1.71

2.81

1.2

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.47

2.81

1.0

1.1

—

(3008607) Semen analysis panel

253

1.52

2.80

1.3

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

150

1.69

2.79

1.0

0.24

0.70

u/ml

1.68

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.06

2.79

2.7

3.6

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

4.56

2.77

2.0

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

774

3463

1.13

2.75

2.9

2.1

13.17

13.04

3.38

767

3406

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

143

1.70

2.75

1.2

12.95

17.90

nmol/l

1.09

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

128

1.74

2.73

4.0

2.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

113

1.79

2.73

1.1

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.41

2.68

9.8

8.3

—

(40762887) Creatinine [Moles/volume] in Blood

2.99

2.66

1.1

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

220

1.54

2.65

1.0

0.25

2.60

u/ml

1.43

163

(3015350) Toxocara sp Ab [Presence] in Serum

3.48

2.62

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

134

1.70

2.60

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

194

1.57

2.54

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

243

993

1.24

2.53

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

239

1.51

2.53

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.86

2.50

1.4

1.3

—

(40759632) Porphyrins [Mass/mass] in Stool

3.28

2.48

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

129

1.69

2.44

1.1

1.0

—

(3018133) Calcium [Moles/volume] in Urine

309

1.43

2.39

2.0

2.3

2.57

2.86

mmol/l

0.62

287

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.90

2.35

6.6

4.2

—

(3034614) HLA Ag [Interpretation]

2.28

2.30

1.4

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

171

1.57

2.30

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

124

1.68

2.28

2.8

3.2

115.15

85.52

pmol/l

0.11

(3032743) Legionella sp IgG Ab [Presence] in Serum

105

1.74

2.27

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

258

1.45

2.26

8.5

4.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.51

2.24

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

197

1.52

2.22

1.6

—

(3041184) Isoniazid [Presence] in Urine

2.93

2.21

2.6

2.8

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

2.53

2.20

1.1

28.45

37.19

0.87

(3044009) aPTT.lupus sensitive (LA screen)

173

1.55

2.20

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

231

1.47

2.18

5.1

5.2

58.99

44.09

g/mol

0.18

210

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

179

1.53

2.11

1.3

1.2

46.11

45.12

mg/l

0.08

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1336

6249

1.09

2.11

1.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

163

1.55

2.10

1.0

0.22

1.42

u/ml

1.05

105

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

100

1.72

2.10

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

221

1.47

2.08

1.0

0.09

1.66

u/ml

1.63

167

(40761995) Spermatozoa Progressive [#/volume] in Semen

151

966

0.79

2.08

3.0

3.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

112

1.67

2.08

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

151

965

0.79

2.06

5.9

6.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.86

2.03

10.9

9.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.01

2.03

1.2

1.1

238.23

236.30

nmol/l

0.02

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

109

1.67

2.03

1.6

2.0

178.93

176.15

ug/g

0.03

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.77

1.92

1.1

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.19

1.91

1.1

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.99

1.90

1.2

1.1

1.23

0.90

u/field

0.98

(3033799) Differential panel - Peritoneal fluid

129

509

1.28

1.90

1.9

2.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1705

8089

1.07

1.89

1.5

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1660

8979

0.93

1.88

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1662

8984

0.94

1.85

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

124

1.59

1.85

1.2

1.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

5.07

1.83

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1654

8937

0.94

1.83

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1661

8964

0.94

1.78

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

368

1.32

1.76

2.6

3.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.81

1.76

1.3

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

207

1254

0.84

1.73

1.3

—

(36303858) Crystals [Presence] in Urine

2.67

1.71

1.1

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.88

1.65

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

259

1.37

1.63

1.2

1.4

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.03

1.62

5.2

5.7

3.83

9.04

mg/l

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.03

1.62

1.0

131.10

237.28

pmol/l

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.38

1.58

1.2

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.80

1.56

8.3

6.3

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

118

1.55

1.3

1.1

8.46

3.22

u/ml

0.31

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

147

1.48

1.54

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.74

1.53

1.7

1.6

0.00

0.15

u/l

—

(3006598) pH of Arterial cord blood

2.00

1.48

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.12

1.48

1.2

1.0

2.15

3.42

1.06

(3007147) Virus identified in Stool by Electron microscopy

3.62

1.46

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.93

1.45

4.4

2.5

—

(3002853) Influenza virus B Ab [Titer] in Serum

3.04

1.44

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.78

1.44

1.0

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.87

1.42

1.0

0.10

0.32

u/ml

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.95

1.40

9.5

7.7

42.00

49.42

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.06

1.39

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

200

861

1.18

1.38

2.9

3.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1787

9530

0.95

1.36

1.5

—

(3022725) Serotonin [Moles/volume] in Serum

1.69

1.35

1.5

1.6

866.23

1015.02

nmol/l

0.21

(3022670) pH of Venous cord blood

1.97

1.35

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.56

1.34

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

148

1.44

1.33

4.7

2.6

5.79

10.89

—

(3029612) Listeria sp Ab [Titer] in Serum

1.79

1.33

1.3

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.17

1.31

1.2

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

816

4456

0.93

1.31

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

357

1.26

1.25

1.4

26.15

24.52

g/l

0.44

267

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.25

1.21

1.0

1.1

1620.00

2833.89

titre

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.94

1.21

2.5

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.94

1.21

1.2

1.1

68.50

66.13

0.17

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

434

2415

0.91

1.13

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.36

1.12

1.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

154

1.38

1.11

1.1

6.11

10.26

u/ml

0.68

106

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

150

1.39

1.10

1.3

1.15

1.31

ml/s/173m2

0.38

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.17

1.10

1.0

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

141

604

1.18

1.09

2.1

2.0

6042.99

3349.79

e6/l

0.20

427

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.54

1.08

1.4

1.8

0.67

0.65

umol/l

0.08

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.57

1.07

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.57

1.07

1.0

0.26

0.36

u/ml

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.53

1.06

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.98

1.04

1.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.92

1.02

1.1

2.3

104.40

95.15

ug/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.66

1.02

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.53

0.99

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

106

1.43

0.99

1.1

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

146

1.35

0.95

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.52

0.92

1.0

0.18

0.62

u/ml

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.88

0.88

1.0

0.15

0.13

u/ml

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.88

0.88

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.84

0.86

1.1

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.59

0.85

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.59

0.85

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.65

0.84

5.5

5.7

0.20

0.23

mmol/l

0.18

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

125

545

1.16

0.84

2.0

1.9

21042.26

11227.41

e6/l

0.29

295

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.83

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.81

0.80

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

356

1.20

0.80

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.54

0.80

1.1

1.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.69

0.79

1.0

5.50

0.44

u/ml

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.65

0.79

1.2

1.76

2.37

mmol/24h

1.05

(3036312) Salmon IgE Ab [Units/volume] in Serum

138

1.32

0.79

1.1

0.50

1.67

u/ml

1.15

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

138

611

1.14

0.78

1.8

2.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.69

0.75

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.87

0.74

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.69

0.73

2.4

2.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.64

0.73

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3357

16599

1.03

0.72

1.5

—

(3044007) Cell count panel - Peritoneal fluid

110

485

1.15

0.68

1.9

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.69

0.68

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

1.69

0.67

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

281

1.19

0.64

6.0

8.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

135

1.28

0.62

1.0

—

(40760410) HLA-B [Type] by High resolution

1.44

0.62

1.0

—

(40760409) HLA-A [Type] by High resolution

1.44

0.62

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.40

0.59

1.0

0.32

0.37

u/ml

—

(3013762) Body weight Measured

101

0.70

0.58

1.1

—

(46236302) HLA-C [Type] by High resolution typing

1.41

0.57

1.0

—

(40763590) HLA-DQ beta [Type]

1.41

0.57

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.69

0.57

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

291

1582

0.93

0.55

1.3

1.2

1.49

1.54

g/l

2.39

291

1582

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.43

0.55

1.1

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.43

0.55

1.1

—

(3013862) HLA-DP [Type]

1.39

0.54

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

415

2224

0.94

0.52

1.4

1.3

184.33

198.03

pmol/l

0.23

415

2224

(3049233) Organic acids panel - Urine

1.61

0.51

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

131

1.24

0.48

1.5

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

132

1.23

0.46

1.5

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.30

0.44

1.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

134

1.21

0.41

1.1

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

103

1.23

0.38

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

220

1047

1.06

0.38

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1854

9203

1.02

0.37

1.7

1.5

4.69

3.30

mg/l

3.41

1483

6016

(3032641) Amino acids panel - Urine

1.36

0.32

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

128

696

0.93

0.31

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

331

1.10

0.30

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.33

0.29

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

181

0.87

0.28

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.21

0.27

2.3

2.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.20

0.27

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.27

0.26

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

194

1.12

0.26

1.6

1.4

0.25

0.22

umol/l

0.14

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.27

0.26

3.8

5.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

118

1.16

0.25

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.72

0.25

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

307

1.09

0.24

6.1

5.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

350

1714

1.03

0.24

1.4

1.3

30.61

32.63

nmol/l

0.66

312

1597

(46235168) Fasting glucose [Moles/volume] in Blood

279

1.09

0.22

1.2

7.51

7.13

mmol/l

0.22

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

0.22

0.0

2.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.17

0.19

1.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.22

0.19

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.22

0.19

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.14

0.18

1.1

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

273

0.93

0.17

2.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.17

0.16

1.3

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

109

1.12

0.15

1.1

1.2

0.60

1.30

umol/24h

—

(3003157) Bacteria [#/volume] in Mother's milk

1.16

0.14

7.5

6.6

—

(40758358) Immune stain study

1.14

0.10

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.80

0.08

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.90

0.05

1.8

1.1

—

(3025130) Human papilloma virus identified in Specimen

648

3265

1.01

0.04

1.8

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2209

11219

1.00

0.04

1.5

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.09

0.03

3.6

2.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.06

0.03

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.2

1.5

—

(3022475) Manganese [Moles/volume] in Blood

135

1.01

0.00

1.3

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.93

-0.00

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_PARASETAMOL – Parasetamol

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Parasetamol

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Parasetamol (RX_PARASETAMOL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints